Advanzeon Solutions, Inc. - Annual Report: 2005 (Form 10-K)
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
þ | Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the fiscal year ended May 31, 2005 or
o | Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
For the transition period from to
Commission file number 1-9927
COMPREHENSIVE CARE CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware (State or other jurisdiction of incorporation or organization) |
95-2594724 (IRS Employer Identification No.) |
|
204 South Hoover Blvd., Suite 200 Tampa, Florida (Address of principal executive offices) |
33609 (Zip Code) |
(813) 288-4808
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(g) of the Act:
Title of each class
Common Stock, Par Value $.01 per share
7 1/2% Convertible Subordinated Debentures due 2010
Common Stock, Par Value $.01 per share
7 1/2% Convertible Subordinated Debentures due 2010
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the Registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days. Yes þ No o
Indicate
by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act). Yes o No þ
Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation
S-K is not contained herein, and will not be contained, to the best of Registrants knowledge, in
definitive proxy or information statements incorporated by reference in Part III of this Form 10-K
or any amendment to this Form 10-K. þ
Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange
Act Rule 12b-2). Yes o No þ
The aggregate market value of voting stock held by non-affiliates of the Registrant on
November 30, 2004, was $7,046,321 based on the average bid and ask price of the Common Stock on
November 30, 2004, as reported on the Over-The-Counter Bulletin Board.
At August 12, 2005, the Registrant had 5,689,544 shares of Common Stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
The information required by Part III of this Annual Report on Form 10-K, to the extent not set
forth herein, is incorporated herein by reference from Comprehensive Care Corporations definitive
proxy statement relating to the annual meeting of stockholders to be held in 2005, which definitive
proxy statement shall be filed with the Securities and Exchange Commission within 120 days after
the end of the fiscal year to which this Annual Report relates.
TABLE OF CONTENTS
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
PART I
Item 1. BUSINESS
CAUTIONARY STATEMENT FOR THE PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995: Certain information included in this annual report on Form 10-K and
in other Company reports, SEC filings, statements, and presentations is forward looking within the
meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to,
statements concerning the Companys anticipated operating results, financial resources, increases
in revenues, increased profitability, interest expense, growth and expansion, and the ability to
obtain new behavioral healthcare contracts. Such forward-looking information involves important
risks and uncertainties that could significantly affect actual results and cause them to differ
materially from expectations expressed herein and in other Company reports, SEC filings,
statements, and presentations. These risks and uncertainties include local, regional, and national
economic and political conditions, the effect of governmental regulation, the competitive
environment in which the Company operates, and other risks detailed from time to time in the
Companys SEC reports.
Overview
Comprehensive Care Corporation® (referred to herein as the Company,
CompCare ®(1), we, our or us) is a Delaware Corporation organized in 1969.
Unless the context otherwise requires, all references to the Company include the Companys
principal operating subsidiary, Comprehensive Behavioral Care, Inc.SM (2) (CBC) and
subsidiary corporations.
Comprehensive Care Corporation, primarily through its wholly-owned subsidiary, Comprehensive
Behavioral Care, Inc., provides managed care services in the behavioral health and psychiatric
fields, which is its only operating segment. We manage the delivery of a continuum of psychiatric
and substance abuse services to commercial, Medicare, and Medicaid members on behalf of employers,
health plans, government organizations, third-party claims administrators, and commercial and other
group purchasers of behavioral healthcare services. Our managed care operations include
administrative service agreements, fee-for-service agreements, and capitation contracts. The
customer base for our services includes both private and governmental entities. Our services are
provided primarily by unrelated vendors on a subcontract or subcapitated basis.
The services we provide are delivered through management service agreements (MSOs),
administrative service agreements (ASOs), and capitated contracts. MSOs and ASOs are contractual
obligations under which the Company does not assume any financial risk or responsibility for the
members behavioral healthcare costs. We may provide various managed care functions under MSO and
ASO arrangements, including clinical care management, provider network development, customer
service, claims processing, and information systems reporting. The scope of services under MSO
arrangements is slightly narrower in comparison to those services we perform under ASO
arrangements. Under capitated contracts, the primary payer of healthcare services prepays us a
fixed, per member per month fee for covered psychiatric and substance abuse services regardless of
actual member utilization and the Company assumes the financial risk for the members behavioral
healthcare costs. Programs are contracted through inpatient facilities as well as through
experienced outpatient practitioners.
Our managed care activities are performed under the terms of agreements with health
maintenance organizations (HMOs), preferred provider organizations, and other health plans or
payers to provide contracted behavioral healthcare services to subscribing participants. Revenue
under a substantial portion of these agreements is earned monthly based on the number of qualified
participants regardless of services actually provided (generally referred to as capitation
arrangements). The information regarding qualified participants is supplied by our clients and we
rely extensively on the accuracy of the client remittance and other reported information to
determine the amount of revenue to be recognized. Such agreements accounted for 90.2%, or $22.1
million, of revenue for the fiscal year ended May 31, 2005, 85.5%, or $23.6 million, of revenue for
the fiscal year ended May 31, 2004, and 87.4%, or $28.2 million, of revenue for the fiscal year
ended May 31, 2003. The remaining balance of the Companys revenues is earned on a fee-for-service
basis and is recognized as services are rendered.
We currently manage programs through which services are provided to recipients in fifteen
states. Current programs and services include fully integrated, capitated behavioral healthcare
services, Employee Assistance
(1) | CompCare is a registered trademark of Comprehensive Care Corporation. | |
(2) | Comprehensive Behavioral Care, Inc. is a registered service mark of the Company. |
2
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Programs (EAPs), case management/utilization review services, administrative services management,
provider sponsored health plan development, preferred provider network development, management and
physician advisor reviews, and overall care management services. We also provide prior and
concurrent authorization for physician-prescribed psychotropic medications for a major Medicaid HMO
in Indiana and Michigan. Members are generally directed to CompCare by their employer, health
plan, or physician and receive an initial authorization for an assessment. Based upon the initial
assessment, a treatment plan is established for the member. Fully integrated capitated lives (i.e.
where the company has contractual, financial risk) totaled approximately 679,000 and 698,000 at May
31, 2005 and 2004, respectively. Combined MSO and ASO lives were approximately 245,000 and 370,000
at May 31, 2005 and 2004, respectively. EAP lives were approximately 1,700 and 2,000 at May 31,
2005 and 2004, respectively.
Our objective is to provide easily accessible, high quality behavioral healthcare services and
products and to manage costs through measures such as the monitoring of hospital inpatient
admissions and the review of authorizations for various types of outpatient therapy. Our goal is
to combine access to quality behavioral healthcare services with effective management controls in
order to ensure the most cost-effective use of healthcare resources.
Recent Developments
On June 14, 2005, we entered into a Securities Purchase Agreement (the Securities Purchase
Agreement) with Woodcliff Healthcare Investment Partners LLC, a Delaware limited liability company
(Woodcliff), pursuant to which we issued to Woodcliff 14,400 shares of our Series A Convertible
Preferred Stock, par value $50.00 per share (the Series A Shares) for a total purchase price of
$3.6 million in cash, of which we realized approximately $3.4 million in net cash proceeds. Each
Series A Share, the terms of which are governed by a Certificate of Designation, Preferences and
Rights (the Certificate of Designation), which is part of our certificate of incorporation, is
convertible into 294.12 shares of the Companys common stock, subject to anti-dilution and other
customary adjustments. If the Series A Shares were converted into our common stock immediately
after the closing of the transactions contemplated by the Securities Purchase Agreement, the common
stock issuable upon such conversion would represent approximately 43% of the Companys outstanding
common stock, excluding exercises of 1,749,956 options and warrants, which represents all
outstanding options and warrants at such time. The Securities Purchase Agreement provides, among
other things, that we may require Woodcliff to purchase up to approximately 2.95 million shares of
our common stock, subject to our attaining certain financial targets and satisfying other
conditions.
The Certificate of Designation provides, among other things, that the holders of the Series A
Shares have the right to designate a majority of the members of our Board of Directors. These
director designees will not be affiliates or employees of Woodcliff. The number of our directors
that may be designated by the holders of the Series A Shares will decline as and if such holders of
the Series A Shares reduce their ownership of such Series A Shares below certain thresholds. For a
more complete discussion of this transaction and for a copy of the Securities Purchase
Agreement and related transaction documents, see our Current Report on Form 8-K and exhibits
thereto filed with the Securities and Exchange Commission on June 20, 2005.
Sources of Revenue
We provide managed behavioral healthcare and substance abuse services to recipients, primarily
through subcontracts with HMOs who have historically carved out these functions to managed
behavioral healthcare organizations like CompCare. We generally receive a negotiated amount on a
per member per month or capitated basis in exchange for providing these services. We then contract
directly with behavioral healthcare providers who receive a pre-determined, fee-for-service rate or
case rate. Behavioral healthcare providers include psychiatrists, clinical psychologists,
therapists, other licensed healthcare professionals, and hospitals. As of May 31, 2005, we had
approximately 8,000 behavioral healthcare practitioners in our network who are primarily located in
the five states in which the Company has its principal contracts, including Connecticut, Indiana,
Florida, Michigan and Texas. Under such full-risk capitation arrangements, profit is a function of
utilization and the amount of claims payments made to our network providers. We perform periodic
reviews of our current client contracts to determine profitability. In the event a contract is not
profitable, we may seek to revise the terms of the contract or to terminate the agreement in
accordance with the specific contract terms. We may also subcontract with a provider company on a
sub-capitated basis. In cases where we have made sub-capitation arrangements, the outside company
manages
3
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
service delivery through CompCares approved and credentialed network that is guided by
stringent quality standards.
During fiscal 2005, we provided services under capitated arrangements for commercial,
Medicare, Medicaid, and Childrens Health Insurance Program (CHIP) patients in Florida and Texas,
commercial and Medicaid patients in Michigan, Medicaid patients in California and Connecticut, and
commercial patients in Arizona, Georgia, Indiana, Kentucky, Minnesota, New York, North Carolina,
Ohio, South Carolina, and Wisconsin. Our Medicaid, Medicare and CHIP contracts are subject to
agreements with our HMO clients whose contracts with the various governmental agencies may be
subject to renegotiation at the election of the specific agency.
We currently have contracts with seven health plans to provide behavioral healthcare services
under commercial, Medicaid, and CHIP plans. These contracts represent approximately 78.3% and
52.1% of our operating revenue for the fiscal years ended May 31, 2005 and May 31, 2004,
respectively. The terms of each contract are generally for one-year periods and are automatically
renewable for additional one-year periods unless terminated by either party. The loss of one or
more of these clients, without replacement by new business, would negatively affect the financial
condition of the Company. These clients include one Connecticut client accounting for 21.6%, or
$5.3 million, of our operating revenues during fiscal 2005 and one Texas client accounting for
21.5%, or $5.2 million, of our operating revenues during fiscal 2005 (see Note 4(2) and 4(3)
Major Customers/Contracts to the audited, consolidated financial statements).
Growth Strategy
Our objective is to expand our presence in both existing and new managed behavioral healthcare
markets by obtaining contracts with health plans, corporations, government agencies, and other
payers through CompCares reputation of providing quality managed behavioral healthcare services
with the most cost-effective use of healthcare resources. Our principal means for pursuing public
sector business is through the submission of proposals in response to formal, competitive bidding
proceedings that are initiated by health plans or government agencies. We are expanding our focus
to include Medicare Advantage Plans, which are proliferating subsequent to the Medicare
Modernization Act of 2003. We recently entered into a marketing services agreement with Health
Alliance Network, Inc., an external marketing vendor who sells other health care products to our
target commercial clients in a continuing effort to attract more commercial clients. We recently
enhanced our product offering with pharmacy infometrics, which is designed to manage costs for
clients through prescriber profiling and education and through prospective member profiling that
enhances our behavioral case management and disease management products. We believe that this
technology profiling capability enhances our behavioral case management and disease management
products. This technology is made available to our customers through our business relationship
with Comprehensive NeuroScience, Inc., a company that develops new products and services that
support the process of treating neuropsychiatric illness, under a recent letter of agreement.
Pharmacy infometrics is complementary to our current pharmacy management contracts that focus on
prior authorization to control costs. Additionally, during fiscal 2005, we entered into a service
agreement with Eye Care International, Inc. (ECI), a vendor who sells eye care programs, products
and services. This agreement allows us to sell a quantity of ECIs eye care memberships thereby
providing us with additional product offerings for our new and existing clients.
Competition
The behavioral healthcare industry is very competitive and provides products and services that
are price sensitive. We believe that there are approximately 150 managed behavioral healthcare
organizations (MBHOs) providing services for an estimated 227 million covered lives in the United
States. Competitors include both freestanding MBHOs as well as health maintenance organizations
(HMOs) with internal behavioral health units or subsidiaries. Many of these competitors have
revenues, financial resources, and membership substantially larger than ours. We believe that one
freestanding MBHO has approximately 25% of the market based on the number of covered lives. There
are also three to four other mid-sized MBHOs and small local or regional companies with whom
CompCare competes.
Seasonality of Business
Historically and during fiscal 2005, we have experienced consistently low utilization during
our first fiscal quarter, which comprises the months of June, July, and August, and increased
utilization during our fourth fiscal quarter, which comprises the months of March, April and May.
Such variations in utilization impact our costs of care during these months, generally having a
positive impact on our gross margins and operating profits during the
4
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
first fiscal quarter and a negative impact on our gross margins and operating profits during
the fourth quarter. For our fiscal quarter ended May 31, 2005, we experienced higher than expected
utilization costs as compared to the fourth quarter in the previous two fiscal years. We have
attempted to address these high fourth quarter utilization costs through rate increases with
certain of our clients. We cannot assure you, however, that we will not continue to experience
increased utilization costs in our fourth fiscal quarters compared to other quarters.
Government Regulation
CompCare is subject to extensive and evolving state and federal regulations relating to the
nations mental health system as well as changes in Medicaid and Medicare reimbursement that could
have an effect on our profitability. These regulations range from licensure and compliance with
regulations related to insurance companies and other risk-assuming entities, to licensure and
compliance with regulations related to healthcare providers. These laws and regulations may vary
considerably among states. As a result, CompCare may be subject to the specific regulatory approach
adopted by each state for regulation of managed care companies and for providers of behavioral
healthcare treatment services. The Company holds licenses or certificates to perform utilization
review and third party administrator (TPA) services in certain states. Certain of the services
provided by our managed behavioral healthcare subsidiaries may be subject to such licensing
requirements in other states. There can be no assurance that additional utilization review or TPA
licenses will not be required or, if required, that CompCare will qualify to obtain such licenses.
In many states, entities that assume risk under contract with licensed insurance companies or
health plans that retain ultimate financial responsibility have not been considered by state
regulators to be conducting an insurance or HMO business. As a result, we have not sought
licensure as either an insurer or HMO in certain states. If the regulatory positions of these
states were to change, our business could be materially affected until such time as CompCare meets
the regulatory requirements. Currently, we cannot quantify the potential effects of additional
regulation of the managed care industry, but such costs will have an adverse effect on future
operations to the extent that they are not able to be recouped in future managed care contracts.
As of May 31, 2005, we managed approximately 684,000 lives in connection with behavioral and
substance abuse services covered through Medicaid and/or CHIPs in California, Connecticut, Florida,
Michigan and Texas. Any changes in Medicaid funding would ultimately affect our reimbursement and
overall profitability.
The Company is subject to the requirements of the Health Insurance Portability and
Accountability Act of 1996 (HIPAA). One of the purposes of HIPAA is to improve the efficiency
and effectiveness of the healthcare system through standardization of the electronic data
interchange of certain administrative and financial transactions and, also, to protect the security
and privacy of protected health information. Entities subject to HIPAA include some healthcare
providers and all healthcare plans. To enhance the Companys ability to meet the specific
requirements of HIPAA in the future, the Company determined it needed to make a significant
investment in its current information system or in a new information system (see Management
Information Systems below).
Accreditation
To develop standards that effectively evaluate the structure and function of medical and
quality management systems in managed care organizations, the National Committee on Quality
Assurance (NCQA) has developed an extensive review and development process in conjunction with
the managed care industry, healthcare purchasers, state regulators, and consumers. The Standards
for Accreditation of MBHOs used by NCQA reviewers to evaluate an MBHO address the following areas:
quality improvement; utilization management; credentialing; members rights and responsibilities;
and preventative care. These standards validate that an MBHO is founded on principles of quality
and is continuously improving the clinical care and services it provides. NCQA utilizes Health
Plan Employer Data and Information Set (HEDIS), which is a core set of performance measurements
developed to respond to complex but clearly defined employer needs as standards for patient care
and customer satisfaction. CompCares Southeast Region operation was awarded a one-year NCQA
accreditation in July 1999 and Full Accreditation in December 2001. Effective July 22, 2002,
CompCare was again awarded Full Accreditation to July 22, 2005 covering membership in Connecticut,
Florida, Georgia, Indiana and Michigan. On May 6, 2005, we were awarded Full Accreditation with an
expiration date of July 22, 2008. This most recent Full Accreditation covers all CompCare
Commercial, Medicare and Medicaid membership in California, Connecticut, Florida, Georgia, Indiana,
Michigan, and Texas. Full Accreditation is granted for a period of three years to those plans that
have excellent programs for continuous quality improvement and that meet NCQAs rigorous standards.
We believe our NCQA accreditation is beneficial to our clients and their members we serve.
Additionally, NCQA accreditation may be an important consideration to our prospective clients.
5
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Management Information Systems
We are implementing a new managed care information system designed to streamline our clinical
and claims operations and offer significant service improvements to our providers as well as
enhance our ability to continue to comply with HIPAA. The new software will feature state of the
art decision aids to enhance the patient treatment process beginning with member assessment and
initial authorization and continuing through claims payment and encounter evaluation. We believe
this system will readily support continued growth and meet our future business needs. The cost of
the system, which is expected to be implemented during 2006, will be approximately $370,000, of
which $200,000 has been paid to our vendor. Once the new information system is fully implemented,
certain provider partners will have limited access to our network resources, and remote user access
will improve as well.
During fiscal 2005, we transitioned our wide area network, connecting all CompCare locations
together, to virtual private network (VPN) technology. The VPN has significantly improved the
speed and security of connections between our regional offices while reducing our data
telecommunications costs. In addition, the VPN permits secure, high-speed connectivity for our
off-site employees.
Marketing and Sales
Our business development staff is responsible for generating new sales leads and for preparing
proposals and responses to commercial and public sector Requests for Proposals. The Companys
Chief Development Officer manages marketing initiatives in public sector markets. CompCare has
also contracted with Health Alliance Network, Inc. to sell products in commercial markets and has
hired two part-time experienced health care executives to assist in the marketing plan for
commercial markets. In addition, our regional administrative operations personnel strengthen the
Companys marketing efforts by providing a local presence. Sales expectations are integrated into
performance requirements for executive staff and for contracted sales personnel.
Administration and employees
Our executive and administrative offices are located in Tampa, Florida, where we maintain
operations, business development, accounting, reporting and information systems, and provider and
member service functions. Provider management, account management, and certain clinical and
utilization management functions are performed in Connecticut, Michigan, and Texas. We currently
employ approximately 70 full-time and 15 part-time employees.
Corporate Governance
Corporate governance is typically defined as the system that allocates duties and authority
among a companys stockholders, board of directors and management. The stockholders elect the
board and vote on extraordinary matters; the board is the companys governing body, responsible for
hiring, overseeing and evaluating management, particularly the CEO; and management runs the
companys day-to-day operations. Our certificate of incorporation provides for a staggered board
separated into three classes. Our Board of Directors consists of seven directors, five of whom are
independent directors. The primary responsibilities of the Board of Directors are oversight,
counseling and direction to the Companys management in the long-term interests of the Company and
its stockholders. The Boards detailed responsibilities include: (a) selecting, regularly
evaluating the performance of, and approving the compensation of the CEO and other senior
executives; (b) reviewing and, where appropriate, approving the Companys major financial
objectives, strategic and operating plans and actions; (c) overseeing the conduct of the Companys
business to evaluate whether the business is being properly managed; and (d) overseeing the
processes for maintaining the Companys integrity with regard to its consolidated financial
statements and other public disclosures and compliance with law and ethics. The Board of Directors
has delegated to the CEO, working with the Companys other executive officers, the authority and
responsibility for managing the Companys business in a manner consistent with the Companys
standards and practices, and in accordance with any specific plans, instructions or directions of
the Board. The CEO and management are responsible for seeking the advice and, in appropriate
situations, the approval of the Board with respect to extraordinary actions to be undertaken by the
Company.
6
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Available Information
The Companys stockholder website is www.compcare-shareholders.com. The Company makes
available free of charge, through a link to the Securities and Exchange Commissions (SEC)
website, our annual, quarterly, and current reports, and any amendments to these reports, as well
as any beneficial ownership reports of officers and directors filed electronically on Forms 3, 4,
and 5. Information contained on our website or linked through our website is not part of this
report on Form 10-K.
Code of Ethics
We
have adopted a code of ethics applicable to all of our employees,
including our principal executive officer, principal financial
officer, principal accounting officer and persons performing similar
functions. The text of this code of
ethics can be found on our website at www.compcare-shareholders.com. We intend to post
notice of any waiver form, or amendment to, any provision of our code of ethics on our website.
Item 2. PROPERTIES
We do not own any real property. The following table sets forth certain information regarding
our leased properties as of May 31, 2005. All leases are full service leases under which CompCare
bears only those costs of operations and property taxes exceeding the base-year expenses.
Monthly Base | ||||||||
Lease | Rent | |||||||
Name and Location | Expires | (in Dollars) | ||||||
Corporate Headquarters, Regional, Administrative, and Other Offices |
||||||||
Tampa, Florida, Corporate Headquarters, and Southeastern
Regional offices |
2006 | $ | 24,215 | |||||
Grand Prairie, Texas |
2006 | 6,474 | ||||||
Bloomfield Hills, Michigan |
2006 | 4,156 |
Item 3. LEGAL PROCEEDINGS
From time to time, the Company and its subsidiaries may be parties to, and their property is
subject to, ordinary, routine litigation incidental to their business. Claims may exceed insurance
policy limits and the Company or any one of its subsidiaries may have exposure to a liability that
is not covered by insurance. Management is not aware of any such lawsuits that could have a
material adverse impact on the Companys consolidated financial statements.
Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On March 11, 2005, the Company held its 2004 Annual Meeting of Stockholders. The meeting was
held to elect one (1) Class III Director to the Companys Board of Directors and to obtain
stockholder approval to amend the Companys 2002 Incentive Plan.
Stockholders of the Companys common stock, $.01 par value, of record as of January 21, 2005
(the Record Date) were entitled to notice of the Annual Meeting and to vote at such meeting. As
of the Record Date, there were 4,798,547 shares of common stock entitled to vote at the meeting.
Stockholders holding 4,426,635 shares of common stock, representing a majority of the common stock
and representing a quorum (approximately 92.2% of the total shares entitled to vote), were
represented at the meeting either in person or by proxy.
RESULTS OF ELECTION OF DIRECTORS
Stockholders were asked to elect one (1) Class III Director to the Companys Board of
Directors. Set forth below is the name of the person nominated for and elected to serve on the
Companys Board of Directors for a term of three (3) years until the year 2007 Annual Meeting of
Stockholders or until his successor is duly elected and qualified, as well as the results of the
voting for the nominee.
Name | Votes For | Votes Withheld | ||
Robert J. Landis
|
4,342,786 | 83,849 |
7
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
At March 11, 2005, following the election of Mr. Robert J. Landis, the Board of Directors of
the Company was composed of the following four (4) directors: Ms. Mary Jane Johnson, the sole Class
I Director whose term expires at the 2006 Annual Meeting of Stockholders, Mr. Howard A. Savin and
Mr. Eugene L. Froelich, each a Class II Director whose term expires at the 2005 Annual Meeting of
Stockholders, and Mr. Robert J. Landis, the sole Class III Director whose term expires at the 2007
Annual Meeting of Stockholders.
RESULTS OF AMENDMENT OF THE COMPREHENSIVE CARE CORPORATION 2002 INCENTIVE PLAN
Stockholders approved an amendment to the Comprehensive Care Corporation 2002 Incentive Plan
(2002 Plan), which increased the shares of common stock authorized for issuance under the 2002
Plan by 500,000. The 2002 Plan is for use in connection with the issuance of stock, options and
other stock purchase rights to executive officers, key employees, and other persons who render
significant services to the Company and its subsidiaries. The Companys stockholders voted as
follows with respect to the proposal to amend the 2002 Plan:
NUMBER OF SHARES
For | Against | Abstain | Broker Non-Votes | |||
1,837,527 | 417,589 | 15,126 | 2,156,393 |
The holder of our Series A Shares elected five new directors pursuant to the terms of the
Certificate of Designation for such stock as required by the Securities
Purchase Agreement. Four of these directors were appointed on June 20, 2005 and one was appointed
effective July 11, 2005. The transactions consummated pursuant to the Securities Purchase
Agreement were described in our current report on Form 8-K filed with the SEC on June 20, 2005,
which is incorporated by reference herein.
PART II
Item 5. MARKET FOR COMPANYS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
(a) | Market Information Our common stock is traded on the Over-The-Counter Bulletin Board (OTC-BB) under the symbol CHCR. The following table sets forth the range of high and low bid quotations for the common stock, as reported by the OTC-BB, for the fiscal quarters indicated. The market quotations reflect interdealer prices without retail mark-up, markdown or commissions and may not represent actual transactions. |
Price | ||||||||||||
Fiscal Year | High | Low | ||||||||||
2005 |
First Quarter | $ | 1.60 | 1.20 | ||||||||
Second Quarter | 1.60 | 1.10 | ||||||||||
Third Quarter | 1.50 | 1.05 | ||||||||||
Fourth Quarter | 2.00 | 1.45 | ||||||||||
2004 |
First Quarter | 3.00 | 2.15 | |||||||||
Second Quarter | 2.40 | 1.46 | ||||||||||
Third Quarter | 2.02 | 1.35 | ||||||||||
Fourth Quarter | 1.80 | 1.15 |
(b) | Holders As of August 12, 2005, the Company had 1,400 holders of record of our common stock. | ||
(c) | Dividends The Company did not pay any cash dividends on its common stock during any quarter of fiscal 2005, 2004, or 2003 and does not contemplate the initiation of payment of any cash dividends in the foreseeable future. The holders of record of our Series A Shares are entitled to receive dividends in preference to holders of our common stock and any of our equity securities ranking junior to our Series A Shares, when and if declared by our Board. If declared, holders of our Series A Shares will receive dividends in an amount equal to the |
8
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
amount that would have been payable had the Series A Shares been converted into shares of our common stock immediately prior to the declaration of such dividend. No dividends shall be authorized, declared, paid or set apart for payment on any class or series of the Companys stock ranking, as to dividends, on a parity with or junior to the Series A Shares for any period unless full cumulative dividends have been, or contemporaneously are, authorized, declared, paid or set apart in trust for such payment on the Series A Shares. In addition, as long as a majority of the 14,400 shares of our Series A Shares are outstanding, we cannot declare or pay any dividend or other distribution with respect to any equity securities without the affirmative vote of holders of at least 50% of the outstanding shares of Series A Shares. (see Item 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS). | |||
(d) | The equity compensation plan information contained in Item 12 of Part III of this Annual Report is incorporated herein by reference. |
Unregistered Sales of Equity Securities and Use of Proceeds
On March 23, 2005, the Company issued an aggregate of 3,000 shares of its common stock in
exchange for marketing services provided to the Company by one vendor who received shares of the
Companys common stock in lieu of an aggregate of $6,000 of cash compensation. The foregoing sales
of securities were made in reliance upon the exemptions from the registration provisions of the
Securities Act of 1933, as amended, provided for by Section 4(2) thereof for transactions not
involving a public offering.
On February 28, 2005, the Company completed the sale of 725,000 shares of its common stock,
$.01 par value, for $761,250, which the Company reported in a Current Report on
Form 8-K filed with the Securities and Exchange Commission on March 1, 2005. On March 24, 2005, the
Company sold an additional 50,000 shares for $52,500. Aggregate net proceeds to the Company from
these sales were approximately $776,000. The Company has used a portion of such net proceeds and
intends to use the remaining net proceeds for product and sales expansion and working capital
purposes. The shares in these offerings were sold to accredited investors in a private transaction
not involving a public offering. The Company relied on Section 4(2) of the Securities Act of 1933,
as amended (the Act) and Rule 506 of Regulation D promulgated thereunder for an exemption from
the registration requirements of the Act.
Item 6. SELECTED FINANCIAL DATA
Prior to fiscal 1993, CompCare principally engaged in the ownership, operation, and management
of psychiatric and substance abuse programs in Company owned, leased, or unaffiliated hospitals.
During fiscal 1999, we completed our plan to dispose of our hospital business segment. Fiscal 2004
results include a $387,000 charge related to such discontinued operations (see Note 9
Discontinued Operations to the audited, consolidated financial statements).
Fiscal 2003 results include a $7.7 million, non-operating gain related to the IRS settlement
(see Note 12 Income Taxes to the audited, consolidated financial statements). Additionally,
fiscal 2003 results included a $470,000 gain included in discontinued operations, related to the
settlement of one matter, covering our fiscal years 1983 through 1986, involving Medi-Cal
reimbursements paid to Brea Neuropsychiatric Hospital, a facility owned by the Company until its
disposal in fiscal year 1991.
9
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
The selected consolidated financial data that follows should be read in conjunction with the
consolidated financial statements and accompanying notes appearing elsewhere in this report.
Consolidated Statements of Operations Data:
Year Ended May 31, | ||||||||||||||||||||
2005 | 2004 | 2003 | 2002 | 2001 | ||||||||||||||||
(Amounts in thousands, except per share data) | ||||||||||||||||||||
Operating revenues |
$ | 24,473 | $ | 27,583 | $ | 32,104 | $ | 27,625 | $ | 18,192 | ||||||||||
Costs and expenses: |
||||||||||||||||||||
Healthcare operating expenses |
21,298 | 24,178 | 29,201 | 24,625 | 15,326 | |||||||||||||||
General and administrative expenses |
3,078 | 3,385 | 3,459 | 3,544 | 3,842 | |||||||||||||||
Provision for (recovery of) doubtful accounts |
(4 | ) | (7 | ) | 20 | (112 | ) | (439 | ) | |||||||||||
Depreciation and amortization |
96 | 107 | 195 | 342 | 656 | |||||||||||||||
Restructuring expenses |
| | | | (30 | ) | ||||||||||||||
24,468 | 27,663 | 32,875 | 28,399 | 19,355 | ||||||||||||||||
Operating income (loss) from continuing operations
before items shown below |
5 | (80 | ) | (771 | ) | (774 | ) | (1,163 | ) | |||||||||||
Other income (expenses): |
||||||||||||||||||||
Net gain on IRS settlement |
| | 7,717 | | | |||||||||||||||
Loss in connection with prepayment of note receivable |
| (20 | ) | | | (496 | ) | |||||||||||||
Loss on impairment of investment |
(118 | ) | | | | | ||||||||||||||
Gain on sale of assets |
| | 4 | | | |||||||||||||||
Loss on sale of assets |
| | (5 | ) | | | ||||||||||||||
Other non operating income |
88 | 1 | 34 | 40 | 332 | |||||||||||||||
Interest income |
15 | 26 | 47 | 88 | 163 | |||||||||||||||
Interest expense |
(206 | ) | (215 | ) | (181 | ) | (178 | ) | (208 | ) | ||||||||||
(Loss) income from continuing operations before income
taxes |
(216 | ) | (288 | ) | 6,845 | (824 | ) | (1,372 | ) | |||||||||||
Income tax expense |
52 | 102 | 20 | 1 | 35 | |||||||||||||||
(Loss) income from continuing operations |
(268 | ) | (390 | ) | 6,825 | (825 | ) | (1,407 | ) | |||||||||||
(Loss) income from discontinued operations |
| (387 | ) | 633 | | 290 | ||||||||||||||
(Loss) income before cumulative effect of change in
accounting principle |
(268 | ) | (777 | ) | 7,458 | (825 | ) | (1,117 | ) | |||||||||||
Cumulative effect of change in accounting principle |
| | | 55 | | |||||||||||||||
Net (loss) income attributable to common stockholders |
$ | (268 | ) | $ | (777 | ) | $ | 7,458 | $ | (770 | ) | $ | (1,117 | ) | ||||||
(Loss) income per common share basic: |
||||||||||||||||||||
(Loss) income from continuing operations |
$ | (0.05 | ) | $ | (0.09 | ) | $ | 1.75 | $ | (0.21 | ) | $ | (0.37 | ) | ||||||
(Loss) income from discontinued operations |
| (0.09 | ) | 0.16 | | 0.08 | ||||||||||||||
Cumulative effect of change in accounting principle |
| | | 0.01 | | |||||||||||||||
Net (loss) income |
$ | (0.05 | ) | $ | (0.18 | ) | $ | 1.91 | $ | (0.20 | ) | $ | (0.29 | ) | ||||||
(Loss) income per common share diluted: |
||||||||||||||||||||
(Loss) income from continuing operations |
$ | (0.05 | ) | $ | (0.09 | ) | $ | 1.57 | $ | (0.21 | ) | $ | (0.37 | ) | ||||||
(Loss) income from discontinued operations |
| (0.09 | ) | 0.15 | | 0.08 | ||||||||||||||
Cumulative effect of change in accounting principle |
| | | 0.01 | | |||||||||||||||
Net (loss) income |
$ | (0.05 | ) | $ | (0.18 | ) | $ | 1.72 | $ | (0.20 | ) | $ | (0.29 | ) | ||||||
Balance Sheet Data: |
||||||||||||||||||||
Working capital deficit |
$ | (3,589 | ) | $ | (4,098 | ) | $ | (4,447 | ) | $ | (12,275 | ) | $ | (11,770 | ) | |||||
Total assets |
6,448 | 6,225 | 6,379 | 11,399 | 9,754 | |||||||||||||||
Total long-term debt and capital lease obligations |
2,375 | 2,364 | 2,298 | 2,264 | 2,244 | |||||||||||||||
Stockholders deficit |
$ | (4,117 | ) | $ | (4,725 | ) | $ | (4,990 | ) | $ | (12,519 | ) | $ | (11,778 | ) |
10
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Item 7. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
This Annual Report on Form 10-K includes forward-looking statements, the realization of which
may be impacted by certain important factors discussed below under Risk Factors Important
Factors Related to Forward-Looking Statements and Associated Risks.
Overview
Comprehensive Care Corporation is a Delaware corporation organized in 1969. The Company,
primarily through its wholly owned subsidiary, Comprehensive Behavioral Care, Inc., provides
managed care services in the behavioral health and psychiatric fields, which is its only operating
segment. The Company manages the delivery of a continuum of psychiatric and substance abuse
services to commercial, Medicare, and Medicaid members on behalf of employers, health plans,
government organizations, third-party claims administrators, and commercial and other group
purchasers of behavioral healthcare services. The managed care operations include administrative
service agreements, fee-for-service agreements, and capitation contracts. The customer base for
its services includes both private and governmental entities. The Companys services are provided
primarily by unrelated vendors on a subcontract or subcapitated basis.
We currently depend, and expect to continue to depend in the near future, upon a relatively
small number of customers for a significant percentage of our operating revenues. A significant
reduction in sales to any of our large customers or a customer exerting significant pricing and
margin pressures on us would have a material adverse effect on our results of operations. In the
past, some of our customers have terminated their arrangements with us or have significantly
reduced the amount of services requested from us. There can be no assurance that present or future
customers will not terminate their arrangements with us or significantly reduce the amount of
services requested from us. Any such termination of a relationship or reduction in use of our
services could have a material adverse effect on our results of operations or financial condition
(see Factors Affecting Future Results and Note 4 Major Contracts/Customers to the audited,
consolidated financial statements).
For the fiscal year ended May 31, 2005, the Company reported a loss from continuing operations
and net loss of $268,000, or $0.05 loss per share (basic and diluted). During the comparable
period of the prior fiscal year, the Company reported a loss from continuing operations of
$390,000, or $0.09 loss per share (basic and diluted), and a net loss of $777,000, or $0.18 loss
per share (basic and diluted).
Effective June 14, 2005, the Company completed a sale of 14,400 shares of its Series A Shares
to one investor for approximately $3.4 million in net cash proceeds to the
Company (see Note 17(1) Subsequent Events to the audited, consolidated financial statements).
Additionally, on March 24, 2005, the Company completed the sale of 50,000 shares of its common
stock, $.01 par value (the Shares), for $52,500 in net cash proceeds, to conclude the Companys
private placement, which generated approximately $776,000 in aggregate net proceeds during February
and March 2005.
The following table sets forth our operating income (loss) for the fiscal years ended May 31,
2005 and 2004:
Consolidated | Consolidated | |||||||
Operations | Operations | |||||||
Fiscal 2005 | Fiscal 2004 | |||||||
Operating revenues |
$ | 24,473 | $ | 27,583 | ||||
Healthcare operating expenses |
21,298 | 24,178 | ||||||
General and administrative expenses |
3,078 | 3,385 | ||||||
Other operating expenses |
92 | 100 | ||||||
24,468 | 27,663 | |||||||
Operating income (loss) |
$ | 5 | $ | (80 | ) | |||
Results of Operations Year Ended May 31, 2005 as Compared to the Year Ended May 31, 2004.
The Company reported operating income of $5,000 and a net loss of $268,000, or $0.05 loss per
share (basic and diluted) for the fiscal year ended May 31, 2005, compared to an operating loss of
$80,000 and a net loss
11
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
of $777,000, or $0.18 loss per share (basic and diluted), for the fiscal year ended May 31, 2004. Operating revenues decreased by 11.3%, or
approximately $3.1 million, to $24.5 million for the fiscal year ended May 31, 2005 compared
to $27.6 million for the fiscal year ended May 31, 2004. This decrease is primarily attributable
to the loss of one major customer in Florida that accounted for $4.4 million of revenue during the
fiscal year ended May 31, 2004, offset partially by increased revenues primarily in Connecticut and
Texas.
Healthcare operating expenses decreased by approximately $2.9 million, or 11.9%, for the
fiscal year ended May 31, 2005 as compared to the fiscal year ended May 31, 2004. This decrease is
primarily attributable to revenue reductions, along with clinical program improvements resulting in
reduced costs of care, and secondarily to lower personnel costs resulting from restructuring our
regional and corporate operations. Healthcare operating expense as a percentage of operating
revenue decreased by 0.7%, from 87.7% for the fiscal year ended May 31, 2004 to 87.0% for the
fiscal year ended May 31, 2005. This decrease is primarily due to the loss of one major contract in
Florida that consistently returned a high medical loss ratio.
General and administrative expenses decreased by $307,000, or 9.1%, for the fiscal year ended
May 31, 2005 as compared to the fiscal year ended May 31, 2004. This decrease is primarily
attributable to a decrease in salaries and benefits resulting from the Companys restructuring of
regional and corporate operations and less usage of outside professional services. General and
administrative expense as a percentage of operating revenue increased slightly from 12.3% for the
fiscal year ended May 31, 2004 to 12.6% for the fiscal year ended May 31, 2005.
Results
of Operations Year Ended May 31, 2004 As Compared to the Year Ended May 31,
2003.
We reported a net loss of $777,000 and an operating loss of $80,000 for the fiscal year ended
May 31, 2004 compared to net income of $7.5 million and an operating loss of $771,000 for the
fiscal year ended May 31, 2003. Results for the fiscal year ended May 31, 2003 include a $7.7
million non-operating gain in connection with the IRS settlement (see Note 12 Income Taxes to
the audited, consolidated financial statements) and a $470,000 gain included in discontinued
operations, related to the settlement of one matter involving Medi-Cal reimbursements paid to Brea
Neuropsychiatric Hospital, a facility owned by the Company until its disposal in fiscal year 1991,
covering fiscal periods from 1983 through 1986. For the fiscal year ended May 31, 2003, excluding
the $8.2 million, one-time gains from net income would have resulted in a $729,000 net loss ($0.19
loss per basic and diluted share). Additionally, fiscal year 2003 results from discontinued
operations include $88,000 of revenue related to a favorable settlement of one hospital cost report
and the elimination of a $75,000 reserve for another cost report, both pertaining to our hospital
business segment that was discontinued in our fiscal year ended May 31, 1999. Operating revenues
decreased by 14.1%, or $4.5 million, to approximately $27.6 million for the fiscal year ended May
31, 2004 compared to $32.1 million for the fiscal year ended May 31, 2003. Reduced revenues from
Texas CHIP contracts and the effect of terminated contracts in Florida resulted in lower revenues,
but were partially offset by increased business in Connecticut and Texas, and new business in
Michigan.
Healthcare operating expenses decreased by approximately $5.0 million, or 17.2%, for the
fiscal year ended May 31, 2004 as compared to the fiscal year ended May 31, 2003. This decrease is
directly attributable to the loss of revenue as described above. Healthcare operating expense as a
percentage of operating revenue decreased by 3.3%, from 91.0% for the fiscal year ended May 31,
2003 to 87.7% for the fiscal year ended May 31, 2004. This decrease is primarily due to the
termination in January 2003 of one major contract that consistently returned a high medical loss
ratio.
General and administrative expenses, which included $122,000 of legal and consulting services
incurred in connection with one unsuccessful bid in Tennessee, decreased by $74,000, or 2.1%, for
the fiscal year ended May 31, 2004 as compared to the fiscal year ended May 31, 2003. General and
administrative expense as a percentage of operating revenue increased from 10.8% for the fiscal
year ended May 31, 2003 to 12.3% for the fiscal year ended May 31, 2004 due to the previously
described decrease in operating revenue.
Other operating expenses decreased by $115,000 for the fiscal year ended May 31, 2004 compared
to the fiscal year ended May 31, 2003. This decrease is attributable to a reduction in depreciation
expense as a result of specific assets being fully depreciated, and a decrease in bad debt expense.
Seasonality of Business
Historically and during our fiscal year ended May 31, 2005, we have experienced consistently
low utilization during our first fiscal quarter, which comprises the months of June, July, and
August, and increased
12
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
utilization during our fourth fiscal quarter, which comprises the months of
March, April and May. Such variations in utilization impact our costs of care during these months,
generally having a positive impact on our gross margins and operating profits during the first
fiscal quarter and a negative impact on our gross margins and operating profits during the fourth
quarter. For our fiscal
quarter ended May 31, 2005, we experienced higher than expected utilization costs as compared to
the fourth quarter in the previous two fiscal years. We have attempted to address these high
fourth quarter utilization costs through rate increases with certain of our clients. We cannot
assure you, however, that we will not continue to experience increased utilization costs in our
fourth fiscal quarters compared to other quarters.
Liquidity and Capital Resources
During the fiscal year ended May 31, 2005, net cash used in continuing and discontinued
operations amounted to $105,000 and $151,000, respectively. In addition, $46,000 was used to
acquire property and equipment and $788,000 was provided by financing activities, primarily from
the issuance of common stock in a private placement transaction, which generated approximately
$776,000 in aggregate net proceeds during February and March 2005.
During the fiscal year ended May 31, 2005, we had an operating profit of $5,000 and a net loss
of $268,000. As of May 31, 2005, the Company had a working capital deficiency of $3.6 million and
a stockholders deficit of $4.1 million. On June 14, 2005, the Company completed the sale of
14,400 shares of its Series A Shares, $50.00 par value, to one investor for approximately $3.4
million in net cash proceeds to the Company (see Note 17(1) Subsequent Events to the audited,
consolidated financial statements). Additionally, on March 24, 2005, the Company completed the sale
of 50,000 shares of its common stock, $.01 par value (the Shares), for $52,500 in net cash
proceeds, to conclude the Companys private placement, which generated approximately $776,000 in
aggregate net proceeds during February and March 2005. As a result, we believe we have sufficient
working capital to sustain current operations and meet our current obligations during our 2006
fiscal year without the need to raise additional equity or debt financing. In addition, we believe
we have sufficient working capital to meet our capital needs during fiscal 2006, which will include
additional installments toward the $170,000 that remains to be paid in connection with our new
information system. Working capital needs in our 2007 fiscal year and thereafter are expected to be
met by cash generated from continuing operations.
Our unpaid claims liability is estimated using an actuarial paid completion factor methodology
and other statistical analyses. These estimates are subject to the effects of trends in
utilization and other factors. Any significant increase in member utilization that falls outside
of our estimations would increase healthcare operating expenses and may impact our ability to
achieve and sustain profitability and positive cash flow. Although considerable variability is
inherent in such estimates, we believe that our unpaid claims liability is adequate. However,
actual results could differ from the $3.7 million claims payable amount reported as of May 31,
2005.
In October 2004, we submitted a bid to the State of Connecticut in response to its request for
proposal for administrative services only (ASO) in connection with a contract that was expected
to begin by October 1, 2005. On January 7, 2005, the Company was informed that another bidder was
selected to negotiate this ASO contract. If the State of Connecticut is successful in their
negotiations with the selected bidder and the State of Connecticut continues with the
implementation of its ASO plans, the Companys existing contract may be terminated sometime during
the Companys third quarter of fiscal 2006, which begins December 1, 2005. This contract
represented approximately 21.6%, or $5.3 million, of our operating revenue for the fiscal year
ended May 31, 2005 (see Note 4(2) Major Customers/Contracts to the audited, consolidated
financial statements).
13
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
The following is a schedule at May 31, 2005 of our long-term contractual commitments, future
minimum lease payments under non-cancelable operating lease arrangements and other long-term
obligations:
Commitments and Contractual Obligations
Payments Due by Period | ||||||||||||||||||||
Less | ||||||||||||||||||||
Than 1 | 4 5 | After 5 | ||||||||||||||||||
Total | Year | 1 - 3 Years | Years | Years | ||||||||||||||||
(Amounts in thousands) | ||||||||||||||||||||
Long-term Debt Obligations (a) |
$ | 2,244 | | | | 2,244 | ||||||||||||||
Capital Lease Obligations and related interest |
128 | 63 | 65 | | | |||||||||||||||
Operating Lease Obligations |
548 | 481 | 67 | | | |||||||||||||||
Purchase Obligations |
170 | 170 | | | | |||||||||||||||
Total |
$ | 3,090 | 714 | 132 | | 2,244 | ||||||||||||||
(a) | Excludes 7 1/2% in interest payable semi-annually in April and October (see Note 11 Long-term Debt to the audited, consolidated financial statements). |
Critical Accounting Estimates
Our discussion and analysis of our financial condition and results of operations is based upon
the Companys consolidated financial statements, which have been prepared in accordance with
accounting principles generally accepted in the United States of America. The preparation of these
consolidated financial statements requires us to make significant estimates and judgments to
develop the amounts reflected and disclosed in the consolidated financial statements, most notably
our estimate for claims incurred but not yet reported (IBNR). On an on-going basis, we evaluate
the appropriateness of our estimates and we maintain a thorough process to review the application
of our accounting policies. We base our estimates on historical experience and on various other
assumptions that we believe to be reasonable under the circumstances. Actual results may differ
from these estimates under different assumptions or conditions.
We believe our accounting policies specific to our accrued claims payable (IBNR), revenue
recognition, marketable securities, and goodwill involve our most significant judgments and
estimates that are material to our consolidated financial statements (see Note 2 Summary of
Significant Accounting Policies to the audited, consolidated financial statements).
Recent Accounting Pronouncements
On December 16, 2004, the FASB issued Statement No. 123R, Share-Based Payment, which
requires companies to record compensation expense for stock options issued to employees at an
amount determined by the fair value of the options. SFAS No. 123R was initially effective for the
Company in its second quarter of fiscal 2006. However, due to an SEC extension of the compliance
date in April 2005, SFAS No. 123R will now be effective for the Company beginning June 1, 2006. As
such, effective with the Companys first fiscal quarter of fiscal 2007, SFAS No. 123R will
eliminate our ability to account for stock options using the method permitted under APB 25 and
instead require us to recognize compensation expense should the Company issue stock options to its
employees or non-employee directors. The Company is in the process of evaluating the impact
adoption of SFAS No. 123R will have on the consolidated financial statements.
CAUTIONARY STATEMENT FOR THE PURPOSES OF THE SAFE HARBOR PROVISIONS OF THE PRIVATE SECURITIES
LITIGATION REFORM ACT OF 1995: Certain information included in this Annual Report on Form 10-K and
in other Company reports, SEC filings, statements, and presentations is forward looking within the
meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to,
statements concerning the Companys anticipated operating results, financial resources, increases
in revenues, increased profitability, interest expense, growth and expansion, and the ability to
obtain new behavioral healthcare contracts. Such forward-looking information involves important
risks and uncertainties that could significantly affect actual results and cause them to differ
materially from expectations expressed herein and in other Company reports, SEC filings,
statements, and presentations. These risks and uncertainties include local, regional, and national
economic and political conditions, the effect of governmental regulation, the competitive
environment in which the Company operates, and other risks detailed from time to time in the
Companys SEC reports.
14
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Risk Factors
Important Factors Related to Forward-Looking Statements and Associated Risks
This Annual Report on Form 10-K contains certain forward-looking statements that are based on our
current expectations and plans. Although we believe our expectations and plans are reasonable and
made in good faith, we can provide no assurance that they will be achieved. Our forward-looking
statements are not guarantees of future performance and would be significantly affected by the
material risk factors set forth below.
We may not be able to accurately predict utilization of our full-risk contracts resulting in
contracts priced at levels insufficient to ensure profitability.
Managed care operations are at risk for costs incurred to supply agreed upon levels of service.
Failure to anticipate or control costs could have material, adverse effects on the Company.
Providing services on a full-risk capitation basis exposes CompCare to the additional risk that
contracts negotiated and entered into may ultimately be unprofitable if utilization levels require
us to provide services at capitation rates which do not account for or factor in such utilization
levels.
Our existing and potential managed care clients operate in a highly competitive environment and may
be subject to a higher rate of merger, acquisition and regulation than in other industries.
We typically contract with small to medium sized HMOs which may be adversely affected by the
continuing efforts of governmental and third party payers to contain or reduce the costs of
healthcare through various means. Our clients may also determine to manage the behavioral
healthcare benefits in house and, as a result, discontinue contracting with the Company.
Additionally, our clients may be acquired by larger HMOs, in which case there can be no assurance
that the acquiring company would renew our contract.
Many managed care companies, including nine of our existing clients, provide services to groups
covered by Medicaid and/or CHIP programs. Recent state budgetary cutbacks to such programs have
reduced reimbursement rates and could ultimately affect companies such as CompCare.
As of May 31, 2005, we managed approximately 683,000 lives in connection with behavioral and
substance abuse services covered through CHIP and Medicaid programs in Texas and Medicaid in
Connecticut, Florida, and Michigan. Any changes in CHIP or Medicaid reimbursement could ultimately
affect the Company through contract bidding and cost structures with the health plans first
impacted by such changes. Benefits available to Texas CHIP recipients were significantly reduced
for the five-month period September 1, 2003 to January 31, 2004 as a result of legislative bills
passed by the Texas State legislature. Although subsequent legislation restored the majority of
benefits available to CHIP recipients effective February 1, 2004, the temporary reduction in
revenues had a negative impact on the Companys results of operations for the fiscal year ended May
31, 2004. Such changes, if implemented in the future, could have a material, adverse impact on our
operations. Additionally, we cannot predict which states in which we operate may pass legislation
that would reduce our revenue through changes in the reimbursement rates or in the number of
eligible participants. In either case, we may be unable to reduce our costs to a level that would
allow us to maintain current gross margins specific to our Medicaid and CHIP programs.
Because providers are responsible for claims submission, the timing of which is uncertain, we must
estimate the amount of claims incurred but not reported.
Our costs of care include estimated amounts for IBNR. The IBNR is estimated using an actuarial
paid completion factor methodology and other statistical analyses that we continually review and
adjust, if necessary, to reflect any change in the estimated liability. These estimates are
subject to the effects of trends in utilization and other factors. Although considerable
variability is inherent in such estimates, we believe that our unpaid claims liability is adequate.
However, actual results may differ materially from the estimated amounts reported.
A failure of our information systems would significantly impair our ability to serve our customers
and manage our business.
An effective and secure information system, available at all times, is vital to our health plans
and their members. We depend on our computer systems for significant service and management
functions, such as providing membership verification, monitoring utilization, processing provider
claims, and providing regulatory data and other client and managerial reports. Any loss of
availability of our current information system, or implementation failure related to our new
information system currently being developed, would cause a disruption in operations and impact our
performance. There can be no assurance that implementation will be successful or that it will be
completed within the expected timeframe.
15
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
We are subject to intense competition that may prevent us from gaining new customers or pricing our
contracts at levels to achieve sufficient gross margins to ensure profitability.
The Company is continually and aggressively pursuing new business. However, the smaller size and
financial condition of our company has proved a deterrent to some prospective customers.
Additionally, we will likely have difficulty in matching the financial resources expended on
marketing characteristic of our competitors. As a result, we may not be able to realize our
forecasted short and long-term growth plans.
As a result of our dependence on a limited number of customers, the loss of any one of these
customers, or a reduction in business from any one of them, could have a material, adverse effect
on our working capital and future results of operations.
We currently have contracts with seven health plans to provide behavioral healthcare services under
commercial, Medicaid, and CHIP plans. These combined contracts represent approximately 78.3% and
52.1% of our operating revenue for the fiscal years ended May 31, 2005 and May 31, 2004,
respectively, two of which each represented more than 20% of our operating revenues during our
fiscal year ended May 31, 2005. The terms of each contract are generally for one-year periods and
are automatically renewable for additional one-year periods unless terminated by either party. The
loss of one or more of these clients, without replacement by new business, would negatively affect
the financial condition of the Company. In October 2004, the Company submitted a bid to the State
of Connecticut in response to its request for proposal for administrative services only (ASO) in
connection with a contract that is expected to begin by October 1, 2005. On January 7, 2005, the
Company was informed that another bidder was selected to negotiate this ASO contract. If the State
of Connecticut is successful in their negotiations with the selected bidder and the State of
Connecticut continues with the implementation of its ASO plans, the Companys existing contract
will be terminated, which may occur sometime during the Companys third quarter of fiscal 2006,
which begins December 1, 2005 (see Note 4(2) Major
Contracts/Customers to the audited,
consolidated financial statements).
The industry is subject to extensive state and federal regulations, as well as diverse licensure
requirements varying by state. Changes in regulations could affect the profitability of our
contracts or our ability to retain clients or to gain new customers.
CompCare holds licenses or certificates to perform utilization review and TPA services in certain
states. There can be no assurance that additional utilization review or TPA licenses will not be
required or, if required, that CompCare will qualify to obtain such licenses. In many states,
entities that assume risk under contract with licensed insurance companies or health plans have not
been considered by state regulators to be conducting an insurance or HMO business. As a result, we
have not sought licensure as either an insurer or HMO in any state. If the regulatory positions of
these states were to change, our business could be materially affected until such time as we are
able to meet the regulatory requirements, if at all. Additionally, some states may determine to
contract directly with companies such as ours for managed behavioral healthcare services in which
case they may also require us to maintain financial reserves or net worth requirements that we may
not be able to meet. Currently, we cannot quantify the potential effects of additional regulation
of the managed care industry, but such costs will have an adverse effect on future operations to
the extent that they are not able to be recouped in future managed care contracts.
CompCare is subject to the requirements of HIPAA. The purpose of the HIPAA is to improve the
efficiency and effectiveness of the healthcare system through standardization of the electronic
data interchange of certain administrative and financial transactions and to protect the security
and privacy of protected health information. While we expect to meet all compliance rules and
timetables with respect to the HIPAA regulations, failure to do so may result in penalties and have
a material adverse effect on the Companys ability to retain its customers or to gain new business.
We have noted an annual seasonality in the usage of our provider network. Our financial results
may suffer to the extent we cannot adequately manage periods of increased utilization.
Historically and during fiscal 2005, we have experienced consistently low utilization during our
first fiscal quarter, which comprises the months of June, July, and August, and increased
utilization during our fourth fiscal quarter, which comprises the months of March, April and May.
Such variations in utilization impact our costs of care during these months, generally having a
positive impact on our gross margins and operating profits during the first fiscal quarter and a
negative impact on our gross margins and operating profits during the fourth quarter.
16
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Currently, our Series A Preferred Shareholder is able to exercise decisive influence over our major
corporate decisions.
As of June 14, 2005, Woodcliff Healthcare Investment Partners LLC (Woodcliff), as a result of its
purchase of 14,400 shares of our Series A Shares, $50.00 par value, beneficially owned capital
stock representing approximately 43% of the Companys voting power and has the right to designate a
majority of the members of our Board of Directors (see Recent Developments on page 1). As a
result, holders of our common stock are subject to the following risks, among others:
| Woodcliff can exercise decisive influence over the election of directors; | ||
| Woodcliff can exercise decisive influence over major decisions involving the Company and its assets; and | ||
| Woodcliff may have interests that differ from those of the Companys other stockholders. |
The holders of our Series A Shares have significant rights and preferences over the holders of the
common stock.
The holders of our Series A Shares are entitled to receive dividends when declared by our
Board of Directors. The payment of these dividends will take priority over any payment of dividends
on our common stock. The holders of our Series A Shares will have a claim against our assets
senior to the claim of the holders of our common stock in the event of our liquidation, dissolution
or winding-up. The aggregate amount of that senior claim is approximately $3.6 million as of August
1, 2005 and will increase thereafter if such preferred stock accrues dividends and if we issue
additional shares of such preferred stock to Woodcliff pursuant to the terms of the Securities
Purchase Agreement for the Series A Shares.
The holders of our Series A Shares have other rights and preferences, including the following:
| to convert their preferred stock into an increased number of shares of common stock as a result of antidilution adjustments; | ||
| to vote together with the holders of the common stock on an "as-converted" basis on all matters; | ||
| to designate representatives to be appointed to our board of directors and, voting together as a single class, to elect up to five directors; and | ||
| to prevent the creation and issuance of capital stock with rights equal to or superior to those of the Series A Shares. |
We may be unable to sell the eye care memberships in which case our financial results will
suffer to the extent we have revenue from such memberships that is less than the cost we paid to
acquire them.
The Company is actively marketing the eye care memberships we acquired in November 2004, but our
efforts have not yet been successful. If our marketing plan fails with respect to these
memberships, we may have to write off some or all of the $125,000 we paid to acquire them. While
we believe our marketing efforts will be successful, there can be no assurance the Company will
sell a quantity of memberships at prices that will allow us to recover the $125,000 cost.
Assumptions relating to the foregoing involve judgments that are difficult to predict accurately
and are subject to many factors that can materially affect results. Budgeting and other management
decisions are subjective in many respects and thus susceptible to interpretations and periodic
revisions based on actual experience and business developments, the impact of which may cause us to
alter our budgets which may in turn affect the Companys results. In light of the factors that can
materially affect the forward-looking information included herein, the inclusion of such
information should not be regarded as a representation by the Company or any other person that our
objectives or plans will be achieved.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk
While we currently have market risk sensitive instruments, we have no significant exposure to
changing interest rates as the interest rate on our long-term debt is fixed. Additionally, we do
not use derivative financial instruments for investment or trading purposes and our investments are
generally limited to cash deposits.
17
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Item 8. CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Index to Consolidated Financial Statements
Years Ended May 31, 2005, 2004 and 2003
Report of Kirkland, Russ, Murphy & Tapp P.A |
19 | |||
Report of Eisner LLP |
20 | |||
Consolidated Balance Sheets, May 31, 2005 and 2004 |
21 | |||
Consolidated Statements of Operations, Years Ended May 31, 2005, 2004 and 2003 |
22 | |||
Consolidated Statements of Stockholders Deficit, Years Ended May 31, 2005, 2004 and 2003 |
23 | |||
Consolidated Statements of Cash Flows, Years Ended May 31, 2005, 2004 and 2003 |
24 | |||
Notes to Consolidated Financial Statements |
25-39 |
18
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors and Stockholders
Comprehensive Care Corporation
Comprehensive Care Corporation
We have audited the accompanying consolidated balance sheets of Comprehensive Care Corporation
and subsidiaries as of May 31, 2005 and 2004 and the related consolidated statements of operations,
stockholders deficit and cash flows for the fiscal years then ended. These consolidated financial
statements are the responsibility of the Companys management. Our responsibility is to express an
opinion on these consolidated financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting
Oversight Board (United States). Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the consolidated financial statements are free of
material misstatement. An audit includes examining, on a test basis, evidence supporting the
amounts and disclosures in the consolidated financial statements. An audit also includes assessing
the accounting principles used and significant estimates made by management, as well as evaluating
the overall consolidated financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all
material respects, the consolidated financial position of Comprehensive Care Corporation and
subsidiaries as of May 31, 2005 and 2004, and the consolidated results of their operations and
their cash flows for the fiscal years then ended, in conformity with U.S. generally accepted
accounting principles.
/s/ Kirkland, Russ, Murphy & Tapp P.A.
Clearwater, Florida
August 2, 2005
August 2, 2005
19
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Board of Directors and Stockholders
Comprehensive Care Corporation
Comprehensive Care Corporation
We have audited the accompanying consolidated statements of operations, stockholders deficit
and cash flows of Comprehensive Care Corporation and subsidiaries for the year ended May 31, 2003.
These financial statements are the responsibility of the Companys management. Our responsibility
is to express an opinion on these financial statements based on our audit.
We conducted our audit in accordance with the standards of the Public Company Accounting
Oversight Board (United States). Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as evaluating the overall
financial statement presentation. We believe that our audit provides a reasonable basis for our
opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all
material respects, the consolidated results of operations and cash flows of Comprehensive Care
Corporation and subsidiaries for the year ended May 31, 2003, in conformity with U.S. generally
accepted accounting principles.
The Companys working capital deficiency, stockholders deficit, and continued losses from
operations raise substantial doubt about its ability to continue as a going concern. Managements
plans as to these matters are described in Note 3. The accompanying consolidated financial
statements do not include any adjustments that might result from the outcome of this uncertainty.
/s/ Eisner LLP
New York, New York
July 25, 2003
July 25, 2003
20
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Consolidated Balance Sheets
May 31, | ||||||||
2005 | 2004 | |||||||
(Amounts in Thousands) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 3,695 | 3,209 | |||||
Marketable securities |
11 | | ||||||
Accounts receivable, less allowance for doubtful accounts of $5 and
$10, respectively |
113 | 191 | ||||||
Accounts
receivable managed care reinsurance contract |
372 | 553 | ||||||
Other current assets |
481 | 524 | ||||||
Total current assets |
4,672 | 4,477 | ||||||
Property and equipment, net |
384 | 390 | ||||||
Goodwill, net |
991 | 991 | ||||||
Restricted cash |
72 | 325 | ||||||
Other assets |
329 | 42 | ||||||
Total assets |
$ | 6,448 | 6,225 | |||||
LIABILITIES AND STOCKHOLDERS DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable and accrued liabilities |
$ | 1,310 | 1,720 | |||||
Accrued claims payable |
3,730 | 3,647 | ||||||
Accrued reinsurance claims payable |
3,191 | 3,183 | ||||||
Income taxes payable |
30 | 25 | ||||||
Total current liabilities |
8,261 | 8,575 | ||||||
Long-term liabilities: |
||||||||
Long-term debt |
2,244 | 2,244 | ||||||
Other liabilities |
60 | 131 | ||||||
Total long-term liabilities |
2,304 | 2,375 | ||||||
Total liabilities |
10,565 | 10,950 | ||||||
Stockholders deficit: |
||||||||
Preferred stock, $50.00 par value; authorized 18,740 shares; none issued |
| | ||||||
Common stock, $0.01 par value; authorized 12,500,000 shares; issued
and outstanding 5,582,547 and 4,673,048, respectively |
56 | 47 | ||||||
Additional paid-in capital |
53,813 | 52,950 | ||||||
Deferred compensation |
| (4 | ) | |||||
Accumulated deficit |
(57,986 | ) | (57,718 | ) | ||||
Total stockholders deficit |
(4,117 | ) | (4,725 | ) | ||||
Total liabilities and stockholders deficit |
$ | 6,448 | 6,225 | |||||
See accompanying report of independent registered public accounting firm and notes to the consolidated financial statements.
21
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
Year Ended May 31, | ||||||||||||
2005 | 2004 | 2003 | ||||||||||
(Amounts in thousands, except per share data) | ||||||||||||
Operating Revenues |
$ | 24,473 | 27,583 | 32,104 | ||||||||
Costs and Expenses: |
||||||||||||
Healthcare operating expenses |
21,298 | 24,178 | 29,201 | |||||||||
General and administrative expenses |
3,078 | 3,385 | 3,459 | |||||||||
(Recovery of) provision for doubtful accounts |
(4 | ) | (7 | ) | 20 | |||||||
Depreciation and amortization |
96 | 107 | 195 | |||||||||
24,468 | 27,663 | 32,875 | ||||||||||
Operating income (loss) before items shown below |
5 | (80 | ) | (771 | ) | |||||||
Other income (expense): |
||||||||||||
Net gain on IRS settlement |
| | 7,717 | |||||||||
Loss in connection with collection of notes receivable |
| (20 | ) | | ||||||||
Loss on impairment investment in marketable securities |
(118 | ) | | | ||||||||
Gain on sale of assets |
| | 4 | |||||||||
Loss on disposal of assets |
| | (5 | ) | ||||||||
Other non-operating income, net |
88 | 1 | 34 | |||||||||
Interest income |
15 | 26 | 47 | |||||||||
Interest expense |
(206 | ) | (215 | ) | (181 | ) | ||||||
(Loss) income from continuing operations before income taxes |
(216 | ) | (288 | ) | 6,845 | |||||||
Income tax expense |
52 | 102 | 20 | |||||||||
(Loss) income from continuing operations |
(268 | ) | (390 | ) | 6,825 | |||||||
(Loss) income from discontinued operations |
| (387 | ) | 633 | ||||||||
Net (loss) income |
$ | (268 | ) | (777 | ) | 7,458 | ||||||
(Loss) income per common share basic: |
||||||||||||
(Loss) income from continuing operations |
$ | (0.05 | ) | (0.09 | ) | 1.75 | ||||||
(Loss) income from discontinued operations |
| (0.09 | ) | 0.16 | ||||||||
Net (loss) income |
$ | (0.05 | ) | (0.18 | ) | 1.91 | ||||||
(Loss) income per common share diluted: |
||||||||||||
(Loss) income from continuing operations |
$ | (0.05 | ) | (0.09 | ) | 1.57 | ||||||
(Loss) income from discontinued operations |
| (0.09 | ) | 0.15 | ||||||||
Net (loss) income |
$ | (0.05 | ) | (0.18 | ) | 1.72 | ||||||
Weighted average common shares outstanding: |
||||||||||||
Basic |
4,935 | 4,284 | 3,905 | |||||||||
Diluted |
4,935 | 4,284 | 4,343 | |||||||||
See accompanying reports of independent registered public accounting firms and notes to the consolidated financial statements.
22
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS DEFICIT
(In Thousands)
(In Thousands)
ADDITIONAL | Total | |||||||||||||||||||||||
Common Stock | Paid-In | Accumulated | Deferred | Stockholders | ||||||||||||||||||||
Shares | Amount | Capital | Deficit | compensation | Deficit | |||||||||||||||||||
Balance, May 31, 2002 |
3,879 | $ | 39 | 51,842 | (64,399 | ) | (1 | ) | (12,519 | ) | ||||||||||||||
Net income |
| | | 7,458 | | 7,458 | ||||||||||||||||||
Shares issued for executive compensation |
20 | | 20 | | | 20 | ||||||||||||||||||
Compensatory stock options and warrants
granted to non-employees |
| | 48 | | (22 | ) | 26 | |||||||||||||||||
Amortization of deferred compensation |
| | | | 7 | 7 | ||||||||||||||||||
Exercise of stock options |
38 | | 18 | | | 18 | ||||||||||||||||||
Balance, May 31, 2003 |
3,937 | $ | 39 | 51,928 | (56,941 | ) | (16 | ) | (4,990 | ) | ||||||||||||||
Net loss |
| | | (777 | ) | | (777 | ) | ||||||||||||||||
Shares issued in connection with private
placement |
700 | 7 | 964 | | | 971 | ||||||||||||||||||
Compensatory stock options and warrants
granted to non-employees |
20 | 1 | 50 | | (4 | ) | 47 | |||||||||||||||||
Amortization of deferred compensation |
| | | | 16 | 16 | ||||||||||||||||||
Exercise of stock options |
16 | | 8 | | | 8 | ||||||||||||||||||
Balance, May 31, 2004 |
4,673 | $ | 47 | 52,950 | (57,718 | ) | (4 | ) | (4,725 | ) | ||||||||||||||
Net loss |
| | | (268 | ) | | (268 | ) | ||||||||||||||||
Shares issued in connection with private
transactions |
775 | 8 | 535 | | | 543 | ||||||||||||||||||
Compensatory stock options and warrants
granted to non-employees |
18 | | 31 | | | 31 | ||||||||||||||||||
Amortization of deferred compensation |
| | | | 4 | 4 | ||||||||||||||||||
Warrants issued in connection with private
transaction |
| | 234 | | | 234 | ||||||||||||||||||
Exercise of stock options |
117 | 1 | 63 | | | 64 | ||||||||||||||||||
Balance, May 31, 2005 |
5,583 | $ | 56 | 53,813 | (57,986 | ) | | (4,117 | ) | |||||||||||||||
See accompanying reports of independent registered public accounting firms and notes to the consolidated financial statements.
23
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
Year Ended May 31, | ||||||||||||
2005 | 2004 | 2003 | ||||||||||
(Amounts in thousands) | ||||||||||||
Cash flows from operating activities: |
||||||||||||
(Loss) income from continuing operations |
$ | (268 | ) | (390 | ) | 6,825 | ||||||
Adjustments to reconcile (loss) income from continuing operations
to net cash used in operating activities: |
||||||||||||
Depreciation and amortization |
96 | 107 | 195 | |||||||||
Provision for doubtful accounts |
| | 20 | |||||||||
Loss on
impairment investment in marketable securities |
118 | | | |||||||||
Amortization of deferred revenue |
(75 | ) | | | ||||||||
Net gain from IRS settlement |
| | (7,717 | ) | ||||||||
Loss in connection with prepayment of note receivable |
| 20 | | |||||||||
Gain on sale of assets |
| | (4 | ) | ||||||||
Loss on disposal of assets |
| | 5 | |||||||||
Compensation
expense stock issued |
31 | 33 | 20 | |||||||||
Compensation
expense stock options and warrants issued |
4 | 31 | 15 | |||||||||
Changes in assets and liabilities: |
||||||||||||
Accounts receivable, net |
78 | (116 | ) | 229 | ||||||||
Accounts
receivable managed care reinsurance contract |
181 | (199 | ) | 221 | ||||||||
Other receivable |
| | 525 | |||||||||
Other current assets, restricted cash, and other assets |
9 | (4 | ) | 286 | ||||||||
Unbenefitted tax refunds received |
| | (2,258 | ) | ||||||||
Accounts payable and accrued liabilities |
(377 | ) | (270 | ) | (132 | ) | ||||||
Accrued claims payable |
83 | (456 | ) | (532 | ) | |||||||
Accrued reinsurance claims payable |
8 | 66 | 1,098 | |||||||||
Income taxes payable |
5 | 10 | (1 | ) | ||||||||
Net cash used in continuing operations |
(107 | ) | (1,168 | ) | (1,205 | ) | ||||||
Net cash used in discontinued operations |
(151 | ) | (88 | ) | (480 | ) | ||||||
Net cash used in continuing and discontinued operations |
(258 | ) | (1,256 | ) | (1,685 | ) | ||||||
Cash flows from investing activities: |
||||||||||||
Net proceeds from sale of property and equipment, net |
| | 3 | |||||||||
Payment received on note for sale of property and equipment, net |
| 139 | 4 | |||||||||
Additions to property and equipment, net |
(45 | ) | (210 | ) | (77 | ) | ||||||
Net cash used in investing activities |
(45 | ) | (71 | ) | (70 | ) | ||||||
Cash flows from financing activities: |
||||||||||||
Proceeds from the issuance of common stock |
841 | 979 | 18 | |||||||||
Repayment of other liabilities |
(52 | ) | (33 | ) | (13 | ) | ||||||
Net cash provided by financing activities |
789 | 946 | 5 | |||||||||
Net increase (decrease) in cash and cash equivalents |
486 | (381 | ) | (1,750 | ) | |||||||
Cash and cash equivalents at beginning of year |
3,209 | 3,590 | 5,340 | |||||||||
Cash and cash equivalents at end of year |
$ | 3,695 | 3,209 | 3,590 | ||||||||
Supplemental disclosures of cash flow information: |
||||||||||||
Cash paid during the year for |
||||||||||||
Interest |
$ | 206 | 205 | 182 | ||||||||
Income taxes |
$ | 48 | 92 | 22 | ||||||||
Noncash financing and investing activities
|
||||||||||||
Property acquired under capital leases |
$ | 43 | 76 | 49 | ||||||||
See accompanying reports of independent registered public accounting firms and notes to the consolidated financial statements.
24
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note 1 Description of the Companys Business and Basis of Presentation
Comprehensive Care Corporation (the Company or CompCare) is a Delaware Corporation
organized in 1969. Unless the context otherwise requires, all references to the Company include
Comprehensive Behavioral Care, Inc. (CBC) and subsidiary corporations. The Company,
primarily through its wholly owned subsidiary, CBC, provides managed care services in the
behavioral health and psychiatric fields, which is its only operating segment. The Company manages
the delivery of a continuum of psychiatric and substance abuse services to commercial, Medicare,
and Medicaid members on behalf of employers, health plans, government organizations, third-party
claims administrators, and commercial and other group purchasers of behavioral healthcare services.
The Company also provides prior and concurrent authorization for physician-prescribed psychotropic
medications for a major Medicaid HMO in Indiana and Michigan. The managed care operations include
administrative service agreements, fee-for-service agreements, and capitation contracts. The
customer base for its services includes both private and governmental entities. The Companys
services are provided primarily by unrelated vendors on a subcontract or subcapitated basis. The
Companys fiscal year ended May 31, 2005 (fiscal 2005).
Note 2 Summary of Significant Accounting Policies
Principles of Consolidation
The consolidated financial statements include the accounts of Comprehensive Care Corporation
and its wholly owned subsidiaries. Significant inter-company accounts and transactions have been
eliminated in consolidation.
Use of Estimates
The preparation of the consolidated financial statements in conformity with accounting
principles generally accepted in the United States of America requires management to make estimates
and assumptions that affect the amounts reported in the consolidated financial statements and
accompanying notes. Actual results could differ from these estimates.
Revenue Recognition
The Companys managed care activities are performed under the terms of agreements with health
maintenance organizations (HMOs), preferred provider organizations, and other health plans or
payers to provide contracted behavioral healthcare services to subscribing participants. Revenue
under a substantial portion of these agreements is earned monthly based on the number of qualified
participants regardless of services actually provided (generally referred to as capitation
arrangements). The information regarding qualified participants is supplied by the Companys
clients and the Company relies extensively on the accuracy of the client remittance and other
reported information to determine the amount of revenue to be recognized. Such agreements
accounted for 90.2%, or $22.1 million, of revenue for the fiscal year ended May 31, 2005, 85.5%, or
$23.6 million, of revenue for the fiscal year ended May 31, 2004, and 87.4%, or $28.2 million, of
revenue for the fiscal year ended May 31, 2003. The remaining balance of the Companys revenues is
earned on a fee-for-service basis and is recognized as services are rendered.
Healthcare Expense Recognition
The Company attempts to control its costs and risk by entering into contractual relationships
with healthcare providers including hospitals, physician groups and other managed care
organizations either on a sub-capitated, a discounted fee-for-services, or a per-case basis. The
Companys capitation contracts typically exclude risk for chronic care patients. The cost of
healthcare services is recognized in the period that the Company is obligated to provide such
services. Certain contracted healthcare providers assume the financial risk for participant care
rendered by them and they are compensated on a sub-capitated basis.
In cases where the Company retains the financial responsibility for authorizations, hospital
utilization, and the cost of other behavioral healthcare services, the Company establishes an
accrual for estimated claims payable (see Accrued Claims Payable below).
Premium Deficiencies
Estimated future healthcare costs and expenses in excess of estimated future premiums are
recorded as a loss when determinable. No such deficiencies existed at May 31, 2005 or May 31,
2004.
25
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Cash and Cash Equivalents
Cash and cash equivalents consist entirely of funds on deposit in savings and checking
accounts at major financial institutions.
Restricted Cash
During the quarter ended February 28, 2005, the trust agreement specific to the Companys
Directors and Officers liability insurance policy was terminated and all funds, which amounted to
approximately $253,000, were released to the Company. As such, at May 31, 2005, restricted cash
consists only of a $72,000 deposit required under the terms of the Companys Tampa office lease.
Marketable Securities
The Companys marketable securities, which is comprised of one available for sale security,
received in lieu of cash compensation for consulting services provided by the Company to one party,
are reflected in the consolidated balance sheet at fair market value, with unrealized gains or
losses, if any, included in other comprehensive income within stockholders deficit. Realized gains
or losses and declines in value judged to be other than temporary, if any, on available-for-sale
securities are reported in other income (expense). At May 31, 2005, management determined that
the loss on investment in marketable securities is other than temporary in nature and, as such, the
Company recognized an impairment loss of approximately $118,000 during May 2005. Factors considered
in determining whether the loss was other than temporary included the financial condition of the
issuer, the fact that this investment has been in a continuous unrealized loss position since
November 2004 when the Company acquired this security, and the Companys intent to hold this
investment for a period of time sufficient to allow for any anticipated recovery. At May 31, 2005,
after recognizing the impairment loss on this investment, the carrying value of approximately
$11,000 is equal to the fair value of this security. As such, the Company has no unrealized gains
or losses at May 31, 2005.
Property and Equipment
Property and equipment are stated at cost. Depreciation expense is computed using the
straight-line method over the estimated useful lives ranging from 3 to 12 years. Leasehold
improvements are amortized over the shorter of the lease term or the assets useful life.
Depreciation and amortization expense was $96,000, $107,000, and $195,000 for the fiscal years
ended May 31, 2005, 2004 and 2003, respectively.
Goodwill
Goodwill includes costs in excess of fair value of the net assets acquired in purchase
transactions, less amortization.
In June 2001, the Financial Accounting Standards Board (FASB) issued Statements of Financial
Accounting Standards (SFAS) No. 141, Business Combinations and No. 142, Goodwill and Other
Intangible Assets, which establishes new guidance for the treatment of goodwill and other
intangible assets. Pursuant to SFAS 142, which was adopted by the Company effective June 1, 2001,
goodwill is not amortized but is periodically evaluated for impairment to carrying amount, with
decreases in carrying amount recognized immediately. The Company reviews goodwill for impairment
annually, or more frequently if changes in circumstances or the occurrence of events suggest an
impairment exists. The test for impairment of goodwill requires the Company to make estimates about
fair value, which are based on projected future cash flows. In accordance with SFAS 142, the
Company had performed an impairment test within six months of the adoption date and determined that
no impairment of goodwill had occurred as of such date. In addition, the Company performed an
annual impairment test as of May 31, 2005, 2004 and 2003 and determined that no impairment of
goodwill had occurred as of such dates. SFAS 141 requires that the purchase method of accounting
be used for all business combinations initiated after June 30, 2001.
Extinguishment of Debt
In April 2002, the FASB issued Statement No. 145, Rescission of FASB Statements No. 4, 44,
and 64, Amendment of FASB Statement No. 13, and Technical Corrections. This Statement eliminates
the automatic classification of gain or loss on extinguishment of debt as an extraordinary item and
requires that such gain or loss be evaluated for extraordinary classification under the criteria of
Accounting Principles Board No. 30, Reporting Results of
26
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Operations. The Company adopted the provisions of SFAS 145 effective for its fiscal year ended
May 31, 2003 and has reflected gains on settlement of debt as other income instead of as
extraordinary items.
Accrued Claims Payable
The accrued claims payable liability represents the estimated ultimate net amounts owed for
all behavioral healthcare services provided through the respective balance sheet dates, including
estimated amounts for claims incurred but not yet reported (IBNR) to the Company. The unpaid
claims liability is estimated using an actuarial paid completion factor methodology and other
statistical analyses and is continually reviewed and adjusted, if necessary, to reflect any change
in the estimated liability. These estimates are subject to the effects of trends in utilization and
other factors. However, actual claims incurred could differ from the estimated claims payable
amount reported as of May 31, 2005 and 2004. Although considerable variability is inherent in such
estimates, management believes that the unpaid claims liability is adequate.
Accrued Reinsurance Claims Payable
The accrued reinsurance claims payable liability represents amounts payable to providers under
a state reinsurance program associated with the Companys contract to provide behavioral healthcare
services to members of a Connecticut HMO (see Note 4 (2) Major Contracts/Customers).
Income Taxes
The Company has adopted Statement of Financial Accounting Standards (SFAS) No. 109,
Accounting for Income Taxes. Under the asset and liability method of SFAS No. 109, deferred tax
assets and liabilities are recognized for the future tax consequences attributable to net operating
loss carryforwards and to differences between the financial statement carrying amounts of existing
assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are
measured using enacted tax rates expected to apply to taxable income in the years in which those
temporary differences are expected to be recovered or settled. Under SFAS No. 109, the effect of a
change in tax rates on deferred tax assets or liabilities is recognized in the consolidated
statements of operations in the period that included the enactment. A valuation allowance is
established for deferred tax assets unless their realization is considered more likely than not.
Stock Options
The Company issues stock options to its employees and non-employee directors (optionees)
allowing optionees to purchase the Companys common stock pursuant to shareholder approved stock
option plans. As permitted by Statement of Financial Accounting Standards (SFAS) No. 148,
Accounting for Stock-Based Compensation-Transitional Disclosure, the Company has elected to follow
Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees and related
interpretations in accounting for its employee stock options (APB 25). Under APB 25, in the
event that the exercise price of the Companys employee stock options is less than the market price
of the underlying stock on the date of grant, compensation expense is recognized. No stock-based
employee compensation cost is reflected in net (loss) income, as all options granted under the
Companys employee stock options plans had an exercise price equal to the market value of the
underlying common stock on the date of grant. The following table illustrates the effect on net
(loss) income and (loss) income per share if the Company had applied the fair value recognition
provisions of SFAS No. 148 to stock-based employee compensation.
27
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Fiscal Year Ended May 31, | ||||||||||||
2005 | 2004 | 2003 | ||||||||||
(in thousands except for per share information) | ||||||||||||
Net (loss) income, as reported |
$ | (268 | ) | $ | (777 | ) | $ | 7,458 | ||||
Deduct: |
||||||||||||
Total stock-based employee compensation expense determined
under fair value based method for all awards, net of related tax
effects |
(233 | ) | (211 | ) | (179 | ) | ||||||
Pro forma net (loss) income |
$ | (501 | ) | $ | (988 | ) | $ | 7,279 | ||||
(Loss) income per common share: |
||||||||||||
Basic as reported |
$ | (0.05 | ) | $ | (0.18 | ) | $ | 1.91 | ||||
Basic pro forma |
$ | (0.10 | ) | $ | (0.23 | ) | $ | 1.86 | ||||
Diluted as reported |
$ | (0.05 | ) | $ | (0.18 | ) | $ | 1.72 | ||||
Diluted pro forma |
$ | (0.10 | ) | $ | (0.23 | ) | $ | 1.68 | ||||
The weighted average fair values of options granted were $0.93, $1.31, and $0.72 in fiscal
2005, 2004, and 2003, respectively. For purposes of pro forma disclosures, the estimated fair
value of the options is amortized to expense over the options vesting period.
The fair value of these options was estimated on the date of grant using the Black-Scholes
option-pricing model with the following assumptions:
Fiscal Year Ended May 31, | ||||||||||||
2005 | 2004 | 2003 | ||||||||||
Volatility factor of the expected market price of the
Companys common stock |
95.0 | % | 95.0 | % | 95.0 | % | ||||||
Expected life (in years) of the options |
5 | 3, 4, and 5 | 5 | |||||||||
Risk-free interest rate |
3.9 | % | 3.6 | % | 4.0 | % | ||||||
Dividend yield |
0 | % | 0 | % | 0 | % |
The fair value of options granted to non-employee consultants is being amortized to expense
over the vesting period of the options.
On December 16, 2004, the FASB issued Statement No. 123R, Share-Based Payment, which
requires companies to record compensation expense for stock options issued to employees at an
amount determined by the fair value of the options. SFAS No. 123R was initially effective for the
Company in its second quarter of fiscal 2006. However, due to an SEC extension of the compliance
date in April 2005, SFAS No. 123R will now be effective for the Company beginning June 1, 2006. As
such, effective with the Companys first fiscal quarter of fiscal 2007, SFAS No. 123R will
eliminate the Companys ability to account for stock options using the method permitted under APB
25 and instead require the Company to recognize compensation expense should the Company issue stock
options to its employees or non-employee directors. The Company is in the process of evaluating the
impact adoption of SFAS No. 123R will have on the consolidated financial statements.
During the period January 2005 through March 2005, prior to the extension of the SFAS No. 123R
compliance date, the Company issued to five employees an aggregate of 152,700 options that vested
May 31, 2005, which provided such employees a shorter vesting term for their options than is
normally awarded. If the options had been issued with customary vesting dates and the compliance
date had not been extended, the Company would have recorded compensation expense totaling
approximately $100,000 during fiscal 2006 for the options that were unvested at May 31, 2005.
28
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Per Share data
In calculating basic (loss) income per share, net (loss) income is divided by the weighted
average number of common shares outstanding for the period. Diluted (loss) income per share
reflects the assumed exercise or conversion of all dilutive securities, such as options, warrants,
and convertible debentures. No such exercise or conversion is assumed where the effect is
antidilutive, such as when there is a net loss. The following table sets forth the computation of
basic and diluted (loss) income per share in accordance with Statement No. 128, Earnings Per Share
(amounts in thousands, except per share data):
Fiscal Year Ended May 31, | ||||||||||||
2005 | 2004 | 2003 | ||||||||||
Numerator: |
||||||||||||
(Loss) income from continuing operations |
$ | (268 | ) | (390 | ) | 6,825 | ||||||
(Loss) income from discontinued operations |
| (387 | ) | 633 | ||||||||
Numerator for diluted (loss) income per share available to Common
Stockholders |
$ | (268 | ) | (777 | ) | 7,458 | ||||||
Denominator: |
||||||||||||
Weighted average shares |
4,935 | 4,284 | 3,905 | |||||||||
Effect of dilutive securities: |
||||||||||||
Employee stock options |
| | 437 | |||||||||
Warrants |
| | 1 | |||||||||
Denominator for diluted income per share-adjusted weighted
Average shares after assumed exercises |
4,935 | 4,284 | 4,343 | |||||||||
(Loss) income per common share basic: |
||||||||||||
(Loss) income from continuing operations |
$ | (0.05 | ) | (0.09 | ) | 1.75 | ||||||
(Loss) income from discontinued operations |
| (0.09 | ) | 0.16 | ||||||||
Net (loss) income |
$ | (0.05 | ) | (0.18 | ) | 1.91 | ||||||
(Loss) income per common share diluted: |
||||||||||||
(Loss) income from continuing operations |
$ | (0.05 | ) | (0.09 | ) | 1.57 | ||||||
(Loss) income from discontinued operations |
| (0.09 | ) | 0.15 | ||||||||
Net (loss) income |
$ | (0.05 | ) | (0.18 | ) | 1.72 | ||||||
Fair Value of Financial Instruments
FASB Statement No. 107, Disclosures about Fair Value of Financial Instruments requires
disclosure of fair value information about financial instruments for which it is practical to
estimate that value.
For cash and cash equivalents, marketable securities, and restricted cash, the carrying amount
approximates fair value. For long-term debt, the fair value is based on the estimated market price
for the convertible debentures on the last day of the fiscal year.
The carrying amounts and fair values of the Companys financial instruments at May 31, 2005 and 2004 are as follows:
2005 | 2004 | |||||||||||||||
Carrying | Fair | Carrying | Fair | |||||||||||||
Amount | Value | Amount | Value | |||||||||||||
(Amounts in thousands) | ||||||||||||||||
Assets |
||||||||||||||||
Cash and cash equivalents |
$ | 3,695 | 3,695 | 3,209 | 3,209 | |||||||||||
Marketable securities |
11 | 11 | | | ||||||||||||
Restricted cash |
72 | 72 | 325 | 325 | ||||||||||||
Liabilities |
||||||||||||||||
Long-term debt |
$ | 2,244 | 2,237 | 2,244 | 2,118 |
29
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note 3 Liquidity
During the fiscal year ended May 31, 2005, net cash used in continuing and discontinued
operations amounted to $106,000 and $151,000, respectively. In addition, $45,000 was used to
acquire property and equipment and $788,000 was provided by financing activities, primarily from
the issuance of common stock in a private placement transaction, which generated approximately
$776,000 in aggregate net proceeds during February and March 2005.
During the fiscal year ended May 31, 2005, the Company had an operating profit of $5,000 and a
net loss of $268,000. As of May 31, 2005, the Company had a working capital deficiency of $3.6
million and a stockholders deficit of $4.1 million. Effective June 14, 2005, the Company
completed a sale of 14,400 shares of its Series A Convertible Preferred Stock, $50.00 par value
(Series A Shares), to one investor for approximately $3.4 million in net cash proceeds to the
Company (see Note 17(1) Subsequent Events). Additionally, on March 24, 2005, the Company
completed the sale of 50,000 shares of its common stock, $.01 par value, for $52,500 in net cash
proceeds, to conclude the Companys private placement, which generated approximately $776,000 in
aggregate net proceeds during February and March 2005. As a result, management believes the
Company has sufficient working capital to sustain current operations and meet the Companys current
obligations during fiscal 2006 without the need to raise additional equity or debt financing. In
addition, management believes the Company has sufficient working capital to meet the Companys
capital needs during fiscal 2006, which will include additional installments toward the $170,000
that remains to be paid in connection with a new information system. This system has expected
costs of approximately $370,000. Once implemented, this system will enable the Company to continue
to meet HIPAA requirements, streamline our entire clinical and claims functions, and offer service
improvements to our participating providers.
Note 4 Major Contracts/Customers
(1) Beginning January 1, 2003, the Company contracted with a new HMO client to provide
behavioral healthcare services to contracted Medicaid members in Florida. This business accounted
for 16.0%, or $4.4 million, of the Companys operating revenues during the prior fiscal year ended
May 31, 2004. During fiscal 2003, such Medicaid members were serviced by the Company through its
contract with another HMO whose agreements with the Company covered Medicaid, Medicare, and
commercial members and represented a combined 24.1%, or $7.8 million, of the Companys operating
revenue for the twelve months ended May 31, 2003. On December 31, 2002, the Company received a
formal termination notice, effective February 28, 2003, from the prior HMO client with respect to
the Medicare and commercial business. In addition, the acquiring HMO, whose contract with the
Company was scheduled to renew in January 2004, formally advised the Company on October 30, 2003
that it had determined to insource behavioral health and, therefore, would not renew its contract
with the Company. Accordingly, the Companys contract with this HMO customer terminated effective
December 31, 2003.
(2) The Company has one contract to provide behavioral healthcare services to Connecticut
members under contract with one HMO. This agreement represented approximately 21.6%, or $5.3
million, 13.7%, or $3.8 million, and 9.0%, or $2.9 million of the Companys operating revenue for
the fiscal years ended May 31, 2005, 2004, and 2003, respectively. Additionally, this contract
provides that the Company, through its contract with this HMO, receives additional funds directly
from a state reinsurance program for the purpose of paying providers. During the fiscal years ended
May 31, 2005, 2004, and 2003, the Company filed reinsurance claims totaling approximately $2.7
million, $2.1 million, and $3.0 million, respectively. Such claims represent cost reimbursements
and, as such, are not included in the reported operating revenues and are accounted for as
reductions of healthcare operating expenses. As of May 31, 2005 and 2004, the Company has reported
$3.2 million as accrued reinsurance claims payable, with $0.4 and $0.6 million reported as accounts
receivable-managed care reinsurance contracts. In the event that the Company does not collect the
amounts receivable related to reinsurance amounts, the Company could remain liable for the costs of
the specific services provided to members that qualify for such reimbursements. The difference
between the reinsurance receivable amount and the reinsurance payable amount is related to timing
differences between the authorization date, the date the money is received by the Company, and the
date the money is paid to the provider. In certain cases, providers have submitted claims for
authorized services having incorrect service codes or otherwise incorrect information that has
caused payment to be denied by the Company. In such cases, there are contractual and statutory
provisions that allow the provider to appeal a denied claim. If no appeal is received by the
Company within the prescribed amount of time, the Company may be required to remit the reinsurance
funds back to the appropriate party. For non-reinsurance claims incurred but not reported under
this contract, the Company estimates its claims payable using a similar method as that used for
other existing contracts. This HMO has been a customer since March 2001. The original contract term
ended December 31, 2002 and, in accordance with its terms, has automatically renewed for three
consecutive one-year periods, with the current term ending December 31, 2005. In October 2004, the
Company submitted a bid to the State of Connecticut in response to its request for proposal for
administrative services only (ASO) in connection with a contract that is expected to begin by
October 1, 2005. On
30
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
January 7, 2005, the Company was informed that another bidder was selected to negotiate this ASO
contract. If the State of Connecticut is successful in their negotiations with the selected bidder
and the State of Connecticut continues with the implementation of its ASO plans, the Companys
existing contract may be terminated sometime during the Companys third quarter of fiscal 2006,
which begins December 1, 2005.
(3) The Company has contracts with one HMO to provide behavioral healthcare services to
contracted commercial, Medicaid, and Childrens Health Insurance Program (CHIP) members in Texas.
This business accounted for approximately 21.5%, or $5.2 million, 14.5%, or $4.0 million, and
11.9%, or $3.9 million of the Companys operating revenues during the fiscal years ended May 31,
2005, 2004, and 2003, respectively. This HMO has been a customer of the Company since November
1998. The original contract term was for one year and the contract provides for automatic one-year
renewal terms.
(4) During fiscal 2003, the Company had three contracts with one HMO to provide behavioral
healthcare services to Florida members. The combined revenue from these contracts accounted for
11.7%, or $3.8 million, of the Companys operating revenues during such fiscal year. These
contracts covering Florida members terminated effective January 1, 2003.
In general, the Companys contracts with its customers are typically for initial one-year terms,
with automatic annual extensions. Such contracts generally provide for cancellation by either
party with 60 to 90 days written notice.
Note 5 Accounts Receivable
Accounts Receivable of $118,000 at May 31, 2005 and $201,000 at May 31, 2004 consists of
trade receivables resulting from services rendered under managed care capitation contracts.
Accounts Receivable Managed Care Reinsurance Contract of $372,000 at May 31, 2005 and $553,000 at
May 31, 2004 consist of receivables resulting from services rendered under the Connecticut contract
(see Note 4(2) Major Contracts/Customers). The following table summarizes changes in the
Companys allowance for doubtful accounts for the fiscal years ended May 31, 2005, 2004 and 2003:
Balance | Additions | Write-off | ||||||||||||||||||
Beginning | Charged To | Recoveries | of | Balance | ||||||||||||||||
of Year | Expense | * | Accounts | End of Year | ||||||||||||||||
(Amounts in thousands) | ||||||||||||||||||||
Year ended May 31, 2005 |
$ | 10 | 5 | | (10 | ) | 5 | |||||||||||||
Year ended May 31, 2004 |
$ | 27 | 10 | | (27 | ) | 10 | |||||||||||||
Year ended May 31, 2003 |
$ | 8 | 43 | | (24 | ) | 27 |
* Excludes $9,000 in 2005, $17,000 in 2004, and $24,000 in 2003 of recoveries from accounts
previously written off.
Recoveries are reflected on the Companys consolidated statements of operations as a
reduction to the provision for doubtful accounts.
Note
6 Other Current Assets
Other current assets consist of the following:
May 31, | ||||||||
2005 | 2004 | |||||||
(Amounts in thousands) | ||||||||
Accounts
receivable other |
$ | 38 | 37 | |||||
Prepaid insurance |
311 | 315 | ||||||
Other prepaid fees and expenses |
132 | 172 | ||||||
Total other current assets |
$ | 481 | 524 | |||||
31
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note 7 Other Assets
Other assets consist of the following:
May 31, | ||||||||
2005 | 2004 | |||||||
(Amounts in thousands) | ||||||||
Deferred costs eye care memberships |
$ | 125 | | |||||
Deposits |
98 | 20 | ||||||
Other deferred costs |
106 | 22 | ||||||
Total other assets |
$ | 329 | 42 | |||||
Note 8 Property and Equipment, net
Property and equipment, net, consists of the following:
May 31, | ||||||||
2005 | 2004 | |||||||
(Amounts in thousands) | ||||||||
Furniture and equipment |
$ | 2,936 | 3,385 | |||||
Leasehold improvements |
48 | 49 | ||||||
Capitalized leases |
141 | 130 | ||||||
3,125 | 3,564 | |||||||
Less accumulated depreciation and amortization |
(2,741 | ) | (3,174 | ) | ||||
Total property and equipment, net |
$ | 384 | 390 | |||||
Note 9 Discontinued Operations
Results for the fiscal year ended May 31, 2004 include a change in estimate resulting in
a $387,000 charge recorded in August 2003 related to hospital operations disposed of in prior
years, which is included under discontinued operations in the accompanying consolidated financial
statements. The charge primarily relates to settlement of the Companys Fiscal 1999 Medicare cost
report for its Aurora, Colorado facility that was sold by the Company during Fiscal 1999. The
settlement requires the Company to repay $400,000 specific to Fiscal 1999, less approximately
$106,000 in Medicare refunds that were due the Company in connection with its Fiscal 1995 and 1996
Medicare cost report settlements for this same Aurora, Colorado hospital. Further, the Medicare
intermediary accepted the Companys proposed, 24-month, 12.125% installment payment plan to repay
the net amount of approximately $300,000, of which approximately $55,000 remains to be paid as of
May 31, 2005, which is included in accounts payable and accrued expenses in the accompanying
consolidated balance sheet at May 31, 2005.
Discontinued hospital operations for the year ended May 31, 2003 consist of a $470,000 gain on
settlement of a liability and income of $163,000 relating to hospital cost report settlements.
Note 10 Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities consist of the following:
May 31, | ||||||||
2005 | 2004 | |||||||
(Amounts in thousands) | ||||||||
Accounts payable |
$ | 189 | 166 | |||||
Accrued salaries and wages |
118 | 135 | ||||||
Accrued vacation |
92 | 141 | ||||||
Accrued legal and audit |
96 | 84 | ||||||
Other accrued liabilities |
815 | 1,194 | ||||||
Total accounts payable and accrued liabilities |
$ | 1,310 | 1,720 | |||||
32
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note 11 Long-term Debt
Long-term debt consists of the following:
May 31, | ||||||||
2005 | 2004 | |||||||
(Amounts in Thousands) | ||||||||
7 1/2% convertible subordinated debentures due April, 2010, interest
payable semi-annually in April and October* |
$ | 2,244 | 2,244 | |||||
* | At May 31, 2005, the debentures are convertible into 9,044 shares of common stock at a conversion price of $248.12 per share. Following the private transaction completed in June 2005 (see Note 17(1) Subsequent Events), the debentures are convertible into 12,377 shares of common stock at a conversion price of $181.30. |
Note 12 Income Taxes
Provision for income taxes consists of the following:
Fiscal Year Ended May 31, | ||||||||||||
2005 | 2004 | 2003 | ||||||||||
(Amounts in thousands) | ||||||||||||
Current: |
||||||||||||
Federal |
$ | | | | ||||||||
State |
52 | 102 | 20 | |||||||||
$ | 52 | 102 | 20 | |||||||||
Reconciliation between the provision for income tax and the amount computed by applying the
statutory Federal income tax rate (34%) to income (loss) before income tax is as follows:
Fiscal Year Ended May 31, | ||||||||||||
2005 | 2004 | 2003 | ||||||||||
(Amounts in thousands) | ||||||||||||
Income tax provision (benefit) at the statutory tax rate |
$ | (73 | ) | (230 | ) | 2,543 | ||||||
State income tax provision (benefit), net of federal tax effect |
(8 | ) | (26 | ) | 296 | |||||||
Non-taxable gain on IRS settlement |
| | (3,733 | ) | ||||||||
Non-deductible items |
37 | 44 | 54 | |||||||||
Benefit of net operating loss carryforward not recognized |
96 | 314 | 840 | |||||||||
Other, net |
| | 20 | |||||||||
$ | 52 | 102 | 20 | |||||||||
Significant components of the Companys deferred tax assets are as follows:
May 31, | ||||||||
2005 | 2004 | |||||||
(Amounts in thousands) | ||||||||
Deferred Tax Assets: |
||||||||
Net operating loss carryforwards |
$ | 1,347 | 1,332 | |||||
Accrued expenses |
78 | 134 | ||||||
Loss on impairment investment in marketable securities |
45 | | ||||||
Employee benefits and options |
35 | 55 | ||||||
Other, net |
76 | 90 | ||||||
Total Deferred Tax Assets |
1,581 | 1,611 | ||||||
Valuation Allowance |
(1,581 | ) | (1,611 | ) | ||||
Net Deferred Tax Assets |
$ | | | |||||
In Fiscal 2003 the Company settled a tax dispute with the IRS regarding the disallowance of
$12.4 million in previously received tax refunds specific to the Companys Fiscal 1985 and 1986
income tax returns. In accordance with the settlement the Company paid the IRS $2.2 million and
relinquished rights to Federal net operating loss carryforwards of approximately $42.0 million
resulting from losses incurred in fiscal years ended May 31, 1995 through May 31, 2001, and a
minimum tax credit carryover of approximately $0.7 million.
33
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
As a result of the resolution of this matter, the Company extinguished the $12.1 million
liability, which had been recorded for the refunds pending resolution of the dispute, and recorded
a non-operating gain in the quarter ended February 28, 2003 of approximately $7.7 million net of
related expenses, including $2.0 million representing the unrecovered portion of the $2.5 million
of fees previously paid to its tax advisor. The gain represented income per share of $1.97
(diluted income per share of $1.77). No taxable income resulted from the settlement of the
liability.
At May 31, 2005, the Companys Federal net operating loss carryforwards total approximately
$3.5 million resulting from losses incurred in the fiscal years ended May 31, 2002 through 2005,
which expire in 2022 through 2025. The Company may be unable to utilize some or all of its
allowable tax deductions or losses, which depends upon factors including the availability of
sufficient taxable income from which to deduct such losses during limited carryover periods. The
private placement transaction completed subsequent to May 31, 2005 constitutes a change of
ownership under IRS rules and, as a result, will limit the Companys tax benefits beginning in
fiscal 2006 (see Note 17(1) Subsequent Events). Further, the Companys ability to use any net
operating losses may be subject to further limitation in the event that the Company issues or
agrees to issue substantial amounts of additional equity.
After consideration of all the evidence, both positive and negative, management has determined
that a valuation allowance at May 31, 2005 and 2004, was necessary to fully offset the deferred tax
assets based on the likelihood of future realization.
Note 13 Employee Benefit Plan
The Company offers a 401(k) Plan (the Plan), which is a defined contribution plan
qualified under Section 401(k) of the Internal Revenue Code, for the benefit of its eligible
employees. All full-time and part-time employees who have attained the age of 21 and have
completed one thousand hours of service are eligible to participate in the Plan. Each participant
may contribute from 2% to 50% of his or her compensation to the Plan up to the annual maximum
allowed amount, which was $14,000 during Calendar 2005, subject to limitations on the highly
compensated employees to ensure the Plan is non-discriminatory. Company contributions are
discretionary and are determined by the Companys management. The Company did not make a matching
contribution in fiscal 2005. The Companys employer matching contributions were approximately
$2,300, and $9,000 to the Plan in fiscal 2004 and 2003, respectively.
Note 14 Preferred Stock, Common Stock, and Stock Option Plans
Preferred Stock
As of May 31, 2005, there are 18,740 remaining shares authorized and available to issue, and
no outstanding shares of Preferred Stock (see Note 17(1) Subsequent Events). The Company is
authorized to issue shares of Preferred Stock, $50.00 par value, in one or more series, each series
to have such designation and number of shares as the Board of Directors may fix prior to the
issuance of any shares of such series. Each series may have such preferences and relative
participation, optional or special rights with such qualifications, limitations or restrictions
stated in the resolution or resolutions providing for the issuance of such series as may be adopted
from time to time by the Board of Directors prior to the issuance of any such series.
Common Stock
Authorized shares of common stock reserved for possible issuance for convertible debentures
and stock options are as follows at May 31, 2005 (see Note 17(1) Subsequent Events with
respect to shares of common stock reserved for possible issuance for Series A Shares):
Convertible
debentures(a) |
9,044 | |||
Outstanding stock options |
1,343,956 | |||
Possible
future issuance under stock option plans and warrants(b) |
982,503 | |||
Total |
2,335,503 | |||
(a) At May 31, 2005, the debentures are convertible into 9,044 shares of common stock at a
conversion price of $248.12 per share. Following the private transaction completed in June 2005
(see Note 17(1) Subsequent Events), the debentures are convertible into 12,377 shares of common
stock at a conversion price of $181.30.
(b) Includes 100,000 warrants to purchase common stock of the Company issued in prior fiscal years to three consultants for their services to the Company, which included public and investor relations and web site development services. in addition, 306,000 warrants to purchase common stock of the Company were issued to two consultants and two employees as compensation for introducing strategic business partners to the Company. All such warrants were issued in lieu of cash compensation and have five-year terms with exercise prices ranging from $1.09 to $5.00.
(b) Includes 100,000 warrants to purchase common stock of the Company issued in prior fiscal years to three consultants for their services to the Company, which included public and investor relations and web site development services. in addition, 306,000 warrants to purchase common stock of the Company were issued to two consultants and two employees as compensation for introducing strategic business partners to the Company. All such warrants were issued in lieu of cash compensation and have five-year terms with exercise prices ranging from $1.09 to $5.00.
34
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Stock Option Plans
The Company currently has two active incentive plans, the 1995 Incentive Plan and the 2002
Incentive Plan (Plans), that provide for the granting of stock options, stock appreciation
rights, limited stock appreciation rights, and restricted stock grants to eligible employees and
consultants to the Company. Grants issued under the Plans may qualify as Incentive Stock Options
(ISOs) under Section 422A of the Internal Revenue Code. Options for ISOs may be granted for
terms of up to ten years and are generally exercisable in cumulative increments of 50% each six
months. Options for Non-statutory Stock Options (NSOs) may be granted for terms of up to 13
years. The exercise price for ISOs must equal or exceed the fair market value of the shares on the
date of grant, and 65% in the case of other options. The Plans also provide for the full vesting
of all outstanding options under certain change of control events. The maximum number of shares
authorized for issuance is 1,000,000 under the 2002 Incentive Plan and 1,000,000 under the 1995
Incentive Plan. As of May 31, 2005 under the 2002 Incentive Plan, there were 511,000 shares
available for option grants and there were 475,000 options outstanding, of which 445,500 options
were exercisable. Additionally, as of May 31, 2005 under the 1995 Incentive Plan, there were 500
shares available for option grants and there were 748,125 options outstanding, of which 744,875
options were exercisable.
The Company also has a non-qualified stock option plan for its outside directors (the
Directors Plan). Each non-qualified stock option is exercisable at a price equal to the common
stocks fair market value as of the date of grant. Initial grants vest annually in 25% increments
beginning on the first anniversary of the date of grant, provided the individual is still a
director on those dates. Annual grants will become 100% vested as of the first annual meeting of
our stockholders following the date of grant, provided the individual is still a director as of
that date. Such annual grants include options granted to non-employee directors for service on the
various committees of the Board of Directors. An optionee who ceases to be a director shall
forfeit that portion of the option attributable to such vesting dates on or after the date he or
she ceases to be a director. The maximum number of shares authorized for issuance under the
Directors Plan is 250,000. As of May 31, 2005 under the Directors Plan, there were 65,003 shares
available for option grants and there were 120,831 options outstanding, of which 79,165 options
were exercisable.
A summary of the Companys stock option activity and related information for the years ended May 31
is as follows:
Weighted | ||||||||
Average | ||||||||
Shares | Exercise Price | |||||||
Outstanding as of May 31, 2002 |
903,175 | $ | 0.83 | |||||
Granted |
247,999 | 1.03 | ||||||
Exercised |
(38,000 | ) | 0.48 | |||||
Forfeited |
(3,950 | ) | 2.40 | |||||
Outstanding as of May 31, 2003 |
1,109,224 | $ | 0.88 | |||||
Granted |
161,666 | 1.91 | ||||||
Exercised |
(16,500 | ) | 0.47 | |||||
Forfeited |
(25,000 | ) | 1.86 | |||||
Outstanding as of May 31, 2004 |
1,229,390 | $ | 1.00 | |||||
Granted |
250,866 | 1.25 | ||||||
Exercised |
(116,500 | ) | 0.55 | |||||
Forfeited |
(19,800 | ) | 1.97 | |||||
Outstanding as of May 31, 2005 |
1,343,956 | $ | 1.08 | |||||
35
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
A summary of options outstanding and exercisable as of May 31, 2005 follows:
Weighted- | Weighted- | ||||||||||||||||||||
Weighted- | Average | Average | |||||||||||||||||||
Exercise | Average | Remaining | Exercise Price of | ||||||||||||||||||
Options | Price | Exercise | Contractual | Options | Exercisable | ||||||||||||||||
Outstanding | Range | Price | Life | Exercisable | Options | ||||||||||||||||
321,000 |
$ | 0.25-$0.39 | $ | 0.26 | 5.09 | 321,000 | $ | 0.26 | |||||||||||||
420,083 |
$ | 0.51-$0.61 | $ | 0.55 | 5.13 | 420,083 | $ | 0.55 | |||||||||||||
239,033 |
$ | 1.00-$1.40 | $ | 1.20 | 8.97 | 201,283 | $ | 1.22 | |||||||||||||
189,165 |
$ | 1.45-$1.70 | $ | 1.57 | 8.96 | 152,499 | $ | 1.59 | |||||||||||||
77,000 |
$ | 1.95-$2.16 | $ | 2.10 | 8.26 | 77,000 | $ | 2.10 | |||||||||||||
97,675 |
$ | 3.5625-$4.00 | $ | 3.95 | 3.53 | 97,675 | $ | 3.95 | |||||||||||||
1,343,956 |
$ | 0.25-$4.00 | $ | 1.08 | 6.40 | 1,269,540 | $ | 1.06 | |||||||||||||
Note 15 Commitments and Contingencies
Lease Commitments
The Company leases certain facilities and equipment. The facility leases contain escalation
clauses based on the Consumer Price Index and provisions for payment of real estate taxes,
insurance, and maintenance and repair expenses. Total rental expense for all operating leases was
$0.6 million in each of the fiscal years ended May 31, 2005, 2004, and 2003.
Future minimum payments, by year and in the aggregate, under non-cancelable operating leases
with initial or remaining terms of one year or more, consist of the following at May 31, 2005:
Fiscal Year | Operating Leases | |||
(Amounts in thousands) | ||||
2006 |
$ | 481 | ||
2007 |
65 | |||
2008 |
2 | |||
Total minimum lease payments |
$ | 548 | ||
Other Commitments and Contingencies
(1) | In connection with the Companys Preferred Provider Network license in Connecticut, the Company is required to maintain a performance bond during all applicable terms of the license. As such, the Company maintains a performance bond of $2,400,000 in compliance with this requirement. In addition, a contract with one existing client requires the Company to maintain two performance bonds totaling $330,000 throughout the contract term. | |
(2) | Related to the Companys discontinued hospital operations, Medicare guidelines allow the Medicare fiscal intermediary to re-open previously filed cost reports. Management believes that the Companys Fiscal 1998 and 1999 cost reports remain eligible for re-opening at some future date, in which case the intermediary may determine that additional amounts are due to or from Medicare. | |
(3) | The Company is subject to the requirements of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). The purpose of the HIPAA provisions is to improve the efficiency and effectiveness of the healthcare system through standardization of the electronic data interchange of certain administrative and financial transactions and, also, to protect the security and privacy of protected health information. Entities subject to HIPAA include some healthcare providers and all healthcare plans. To meet the specific requirements of HIPAA, the Company determined it needed to make a significant investment in its current information system or in a new information system that would better meet the Companys future needs. As a result, the Company has entered into a Software License Maintenance and Services Agreement with Qualifacts Systems, Inc. (Qualifacts), a vendor that has provided the Company with an immediate, temporary solution to meet HIPAA compliance rules specific to the Electronic Health Care Transactions and Code Sets Standards Model Compliance Plan with the Centers for Medicare and Medicaid Services and, additionally, to design a new, customized management information system that will enable the Company to continue to meet HIPAA requirements in the future. The Company expects to incur approximately $370,000 of costs to customize the Qualifacts system and activate the licenses needed for Qualifacts and other, related third-party software. |
36
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
(4) | The Company is actively marketing eye care memberships it acquired in November 2004. If the Companys marketing plan fails with respect to these memberships, it may have to write off some or all of the $125,000 the Company paid to acquire them (see Note 7 Other Assets). While management believes the Companys marketing efforts will be successful, there can be no assurance the Company will sell a quantity of memberships at prices that will allow the Company to recover the $125,000 cost. | |
(5) | Effective August 1, 2005, the Companys principal operating subsidiary, CBC, entered into a marketing agreement with Health Alliance Network, Inc. (HAN) whereas CBC has agreed to appoint HAN as its primary representative and marketing agent for commercial business (see Note 17(2) Subsequent Events). |
From time to time, the Company and its subsidiaries are also parties and their property is
subject to ordinary, routine litigation incidental to their business, in which case claims may
exceed insurance policy limits and the Company or any one of its subsidiaries may have exposure to
a liability that is not covered by insurance. Management is not aware of any such lawsuits that
could have a material adverse impact on the Companys consolidated financial statements.
37
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note 16 QUARTERLY FINANCIAL INFORMATION (UNAUDITED)
FISCAL 2005 | Quarter Ended | Fiscal Year | ||||||||||||||||||
8/31/04 | 11/30/04 | 2/28/05 | 5/31/05 | Total | ||||||||||||||||
(Amounts in thousands, except per share data) | ||||||||||||||||||||
Operating revenues |
$ | 6,039 | 6,231 | 6,241 | 5,962 | 24,473 | ||||||||||||||
Gross profit |
871 | 903 | 1,107 | 294 | (a) | 3,175 | ||||||||||||||
General and administrative expenses |
702 | 727 | 846 | 803 | 3,078 | |||||||||||||||
Provision for (recovery of) doubtful accounts |
(5 | ) | 1 | (2 | ) | 2 | (4 | ) | ||||||||||||
Depreciation and amortization |
24 | 23 | 24 | 25 | 96 | |||||||||||||||
Other expense |
41 | 38 | 14 | 128 | (b) | 221 | ||||||||||||||
Income (loss) from continuing operations before income taxes |
109 | 114 | 225 | (664 | ) | (216 | ) | |||||||||||||
Income tax expense |
18 | 11 | 13 | 10 | 52 | |||||||||||||||
Net income (loss) from continuing operations |
$ | 91 | 103 | 212 | (674 | ) | (268 | ) | ||||||||||||
Basic income (loss) per common share |
$ | 0.02 | 0.02 | 0.04 | (0.12 | ) | (0.05 | ) | ||||||||||||
Diluted income (loss) per common share |
$ | 0.02 | 0.02 | 0.04 | (0.12 | ) | (0.05 | ) | ||||||||||||
Weighted Average Common Shares Outstanding basic |
4,682 | 4,691 | 4,794 | 5,566 | 4,935 | |||||||||||||||
Weighted Average Common Shares Outstanding diluted |
5,272 | 5,262 | 5,316 | 5,566 | 4,935 | |||||||||||||||
(a) | Includes an $88,000 expense reimbursement received from one former client. |
|
(b) | Includes a loss on impairment of approximately $118,000 with respect to the Companys marketable securities. |
FISCAL 2004 | Quarter Ended | Fiscal Year | ||||||||||||||||||
8/31/03 | 11/30/03 | 2/29/04 | 5/31/04 | Total | ||||||||||||||||
(Amounts in thousands, except per share data) | ||||||||||||||||||||
Operating revenues |
$ | 7,893 | 7,011 | 6,348 | 6,331 | 27,583 | ||||||||||||||
Gross profit |
1,041 | 812 | 828 | 724 | 3,405 | |||||||||||||||
General and administrative expenses |
908 | 970 | 799 | 708 | 3,385 | |||||||||||||||
Provision for (recovery of) doubtful accounts |
(8 | ) | (4 | ) | (2 | ) | 7 | (7 | ) | |||||||||||
Depreciation and amortization |
27 | 28 | 27 | 25 | 107 | |||||||||||||||
Other expense |
35 | 48 | 73 | 52 | 208 | |||||||||||||||
Income (loss) from continuing operations before income taxes |
79 | (230 | ) | (69 | ) | (68 | ) | (288 | ) | |||||||||||
Income tax expense |
17 | 3 | 9 | 73 | 102 | |||||||||||||||
Income (loss) from continuing operations |
62 | (233 | ) | (78 | ) | (141 | ) | (390 | ) | |||||||||||
Loss from discontinued operations |
(387 | ) | | | | (387 | ) | |||||||||||||
Net loss |
$ | (325 | ) | (233 | ) | (78 | ) | (141 | ) | (777 | ) | |||||||||
Income (loss) per common share basic: |
||||||||||||||||||||
Income (loss) from continuing operations |
$ | 0.02 | (0.06 | ) | (0.02 | ) | (0.03 | ) | (0.09 | ) | ||||||||||
Loss from discontinued operations |
(0.10 | ) | | | | (0.09 | ) | |||||||||||||
Net loss |
$ | (0.08 | ) | (0.06 | ) | (0.02 | ) | (0.03 | ) | (0.18 | ) | |||||||||
Income (loss) per common share diluted: |
||||||||||||||||||||
Income (loss) from continuing operations |
$ | 0.01 | (0.06 | ) | (0.02 | ) | (0.03 | ) | (0.09 | ) | ||||||||||
Loss from discontinued operations |
(0.08 | ) | | | | (0.09 | ) | |||||||||||||
Net loss |
$ | (0.07 | ) | (0.06 | ) | (0.02 | ) | (0.03 | ) | (0.18 | ) | |||||||||
Weighted Average Common Shares Outstanding basic |
3,937 | 3,942 | 4,585 | 4,672 | 4,284 | |||||||||||||||
Weighted Average Common Shares Outstanding diluted |
4,725 | 3,942 | 4,585 | 4,672 | 4,284 | |||||||||||||||
38
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note
17 Subsequent Events
(1) | On June 14, 2005, pursuant to a Securities Purchase Agreement (the Securities Purchase Agreement), the Company completed a private transaction for the sale of 14,400 shares of its Series A Convertible Preferred Stock, $50.00 par value (Series A Shares), to one investor for an aggregate of $3,600,000 in gross proceeds to the Company. The Company realized net cash proceeds of approximately $3.4 million thereby reducing its working capital deficiency and stockholders deficit each by approximately $3.4 million as a result of this transaction. The shares issued in connection with this private placement have not been registered and may be resold pursuant to Rule 144 under the general rules and regulations of the Securities Act of 1933 as amended assuming that all of the conditions and provisions of the rule are complied with. The earliest date that these shares would become eligible for resale without a registration statement would be June 14, 2006. Further, each share of the Series A Shares is convertible into 294.12 shares, or 4,235,328 shares, of the Companys common stock, subject to anti-dilution and other customary adjustments. If the shares were converted into the Companys common stock immediately after the closing of the transactions contemplated by the Securities Purchase Agreement, the common stock issuable upon such conversion would represent approximately 43% of the Companys outstanding common stock, excluding exercises of any options or warrants outstanding at such time. Certain members of the Investor are non-management employees of the Company. The Securities Purchase Agreement also provides that the Company may require the Investor to purchase up to approximately 2.95 million shares of the Companys common stock, subject to the Company attaining certain financial targets and satisfying other conditions. | |
(2) | On August 3, 2005, the Companys principle operating subsidiary, Comprehensive Behavioral Care, Inc. (CBC), entered into a marketing agreement (Agreement) with Health Alliance Network, Inc. (HAN) whereas CBC has agreed to appoint HAN as its primary representative and marketing agent for commercial business. Pursuant to the Agreement, HAN will receive a $15,000 monthly fee for its marketing services to CBC plus reimbursement of related travel expenses. HAN will receive three percent of the gross revenues received by CBC from commercial services agreements resulting from introductions made by HAN or its affiliates and approved by CBC. HAN will receive an additional payment with respect to those commercial services agreements exceeding certain pricing targets equal to fifty percent of the gross revenues exceeding such pricing target. Further, CBC will pay HAN a quarterly bonus of $9,000 or $21,000 if the Company achieves certain quarterly profit targets. The maximum payments to HAN, inclusive of all fees and bonuses, shall not exceed $1.0 million in any fiscal year. The Agreement is effective August 1, 2005 for an initial term of twenty-four (24) months and is automatically renewable for additional periods of twelve months each unless terminated by either party. Two of the shareholders of HAN are also part-time senior marketing employees of CBC and, additionally, they are each members of the investment group that recently acquired 14,400 shares of the Companys Series A Shares (see Note 17(1) above). |
Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS
(a) | On June 1, 2004, the Company dismissed Eisner LLP (Eisner) as its independent registered public accounting firm. The determination to dismiss Eisner was made by the Audit Committee of the Board of Directors of the Company and was prompted by economic considerations and, also, the Companys desire to engage a firm with local presence. Eisners New York office had audited the Companys consolidated financial statements for each of the two years ended May 31, 2003, and with respect to which had included in its reports a going concern uncertainty. These reports did not contain any adverse opinion, disclaimer of opinion, or qualification or modification as to audit scope or accounting principles. Since their retention as the Companys independent registered public accounting firm and through June 1, 2004, there were no disagreements with Eisner on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements if not resolved to Eisners satisfaction would have caused Eisner to make reference thereto in their report on the consolidated financial statements of the Company for such years. During the period of their retention there were no reportable events as defined in Item 304(a)(1)(v) of Regulation S-K. | |
(b) | New Independent Registered Public Accounting Firm. On June 1, 2004, the Audit Committee of the Board of Directors of the Company appointed Kirkland, Russ, Murphy & Tapp P.A. (KRMT) to serve as its independent registered public accounting firm for the fiscal year ending May 31, 2004. In the years ended May 31, 2003 and 2002, the Company did not consult KRMT with respect to the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Companys consolidated financial statements, or any other matters or reportable events as set forth in Items 304(a)(2)(i) and (ii) of Regulation S-K. |
39
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Item 9a. CONTROLS AND PROCEDURES
Evaluation of the Companys Disclosure Controls and Internal Controls. As of the end of the period
covered by this report on Form 10-K, the Company evaluated the effectiveness of the design and
operation of its disclosure controls and procedures (Disclosure Controls), and its internal
controls and procedures for financial reporting (Internal Controls). This evaluation (the
Controls Evaluation) was done under the supervision and with the participation of our Chief
Executive Officer (CEO) and Chief Financial Officer (CFO). Rules adopted by the Securities and
Exchange Commission (SEC) require that in this section of the Annual Report on Form 10-K we
present the conclusions of the CEO and the CFO about the effectiveness of our Disclosure Controls
and Internal Controls based on and as of the date of the Controls Evaluation.
Disclosure Controls and Internal Controls. As provided in Rule 13a-14 of the General Rules and
Regulations under the Securities Exchange Act of 1934, as amended, Disclosure Controls are defined
as meaning controls and procedures that are designed with the objective of insuring that
information required to be disclosed in our reports filed under the Securities Exchange Act of
1934, as amended (the Exchange Act), is recorded, processed, designed and reported within the
time periods specified by the SECs rules and forms. Disclosure Controls include, within the
definition under the Exchange Act, and without limitation, controls and procedures designed to
insure that information required to be disclosed by us in our reports is accumulated and
communicated to our management including our CEO and CFO, as appropriate, to allow timely decisions
regarding disclosure. Internal Controls are procedures which are designed with the objective of
providing reasonable assurance that (1) our transactions are properly authorized; (2) our assets
are safeguarded against unauthorized or improper use; and (3) our transactions are properly
recorded and reported, all to permit the preparation of our consolidated financial statements in
conformity with generally accepted accounting principles.
Conclusion. Based on their evaluation, as of the end of the period covered by this annual report
of the effectiveness of our Disclosure Controls, the Chief Executive Officer and Chief Financial
Officer have each concluded that our Disclosure Controls are effective and sufficient to ensure
that we record, process, summarize, and report information required to be disclosed by us in our
periodic reports filed under the Securities Exchange Act within the time periods specified by the
Securities and Exchange Commissions rules and forms.
Subsequent to the date of their evaluation, there have not been any significant changes in our
Internal Controls or in other factors to our knowledge that could significantly affect these
controls, including any corrective action with regard to significant deficiencies and material
weaknesses. The design of any system of controls and procedures is based in part upon certain
assumptions about the likelihood of future events.
Item 9b. OTHER INFORMATION
Effective August 18, 2005, Dr. Howard A. Savin and Kye Hellmers resigned from the Companys
Board of Directors. Prior to resigning from the Board of Directors, Dr. Savin served on the Audit
Committee of the Board of Directors. Dr. Savin and Mr. Hellmers have no disagreements with the
Company or its management relating to the Companys operations, policies or practices.
PART III
Item 10. Executive Officers and Directors of the Company
The information required by this Item with respect to the directors and compliance with
Section 16(a) of the Securities and Exchange Act is incorporated by reference from the information
provided under the headings Board of Directors and Section 16(a) Beneficial Ownership Reporting
Compliance, respectively, contained in our Proxy Statement to be filed with the Securities and
Exchange Commission in connection with the solicitation of proxies for our Annual Meeting of
Stockholders to be held on October 21, 2005.
The information required by this Item with respect to our executive officers is incorporated
herein by reference to our Proxy Statement.
The information required by this Item with respect to our audit committee members and our
audit committee financial expert is incorporated herein by reference from the information provided
under the heading Audit Committee of our Proxy Statement.
40
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
The information required by this Item with respect to our code of business ethics is
incorporated herein by reference from the information provided under the heading Corporate
Governance of our Proxy Statement.
The information required by this Item with respect to material changes to the procedures by
which our stockholders may recommend nominees to our Board of Directors is incorporated herein by
reference from the information provided under the heading Procedures for Submitting Stockholder
Proposals of our Proxy Statement.
Item 11. EXECUTIVE COMPENSATION
The information required by this Item is incorporated by reference from the information
provided under the heading Executive Compensation of our Proxy Statement.
Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
EQUITY COMPENSATION PLAN INFORMATION
The following table summarizes share and exercise price information with respect to the Companys
equity compensation plans (including individual compensation arrangements) under which equity
securities of Comprehensive Care Corporation are authorized for issuance as of May 31, 2005:
(c) | ||||||||||||
(a) | (b) | Number of securities remaining | ||||||||||
Number of securities to | Weighted-average | available for future issuance | ||||||||||
be issued upon exercise | exercise price of | under equity compensation | ||||||||||
of outstanding options, | outstanding options, | plans (excluding securities | ||||||||||
Plan category | warrants and rights | warrants and rights | reflected in column (a)) | |||||||||
Equity compensation
plans approved by
shareholders |
1,343,956 | $ | 1.08 | 576,503 | ||||||||
Equity compensation
plans not approved
by shareholders* |
406,000 | 1.78 | | |||||||||
Total |
1,749,956 | $ | 1.24 | 576,503 | ||||||||
*Consists of 100,000 warrants to purchase common stock of the Company issued in prior fiscal
years to three consultants for their services to
the Company, which included public and investor
relations and web site development services. In addition, 306,000 warrants to purchase common stock
of the Company were issued to two consultants and two employees as compensation for introducing
strategic business partners to the Company. All such warrants were issued in lieu of cash
compensation and have five-year terms with exercise prices ranging from $1.09 to $5.00.
Information required by this Item with respect to Stock Ownership of Certain Beneficial
Owners and Management is incorporated herein by reference from the information provided under the
heading Security Ownership of our Proxy Statement.
Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS
The information relating to the employment agreements with executive officers, stock options,
stay bonuses, stock grants, and other compensation required by this Item is incorporated by
reference from the information provided under the heading Executive Compensation of our Proxy
Statement. During the fiscal year ended May 31, 2005, two executive officers served on the Board
of Directors of the Company and, also, on the Board of Directors for each of the Companys
wholly-owned subsidiary corporations.
Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
The information required by this Item is incorporated by reference from the information
provided under the heading Independent Auditors of our Proxy Statement.
41
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Part IV
Item 15. Exhibits and Financial Statement Schedules
(a)
|
1. | Consolidated Financial Statements Included in Part II of this report: | ||||
Reports of Independent Registered Public Accounting Firms | ||||||
Consolidated Balance Sheets, May 31, 2005 and 2004 | ||||||
Consolidated Statements of Operations, Years Ended May 31, 2005, 2004 and 2003 | ||||||
Consolidated Statements of Stockholders Deficit, Years Ended May 31, 2005, 2004 and 2003 | ||||||
Consolidated Statements of Cash Flows, Years Ended May 31, 2005, 2004 and 2003 | ||||||
Notes to Consolidated Financial Statements | ||||||
2. | Consolidated Financial Statement Schedules: None. |
Other schedules are omitted, as required information is inapplicable or the information is
presented in the consolidated financial statements or related notes.
3. Exhibits:
Number | Description and Reference | |
3.1
|
Restated Certificate of Incorporation as amended. (4) | |
3.2
|
Restated Bylaws as amended July 20, 2000. (8) | |
3.3
|
Bylaw amendment. (6) | |
3.4
|
Certificate of Designation, Preferences, and Rights of Series A Convertible Preferred Stock of Comprehensive Care Corporation. (6) | |
4.1
|
Indenture dated April 25, 1985 between the Company and Bank of America, NT&SA, relating to Convertible Subordinated Debentures. (1) | |
4.2
|
Form of Common Stock Certificate. (14) | |
10.1
|
Form of Stock Option Agreement. *(2) | |
10.2
|
Form of Indemnity Agreement as amended March 24, 1994. *(3) | |
10.3
|
Comprehensive Care Corporation 1995 Incentive Plan, as amended on November 17, 1998. (9) | |
10.4
|
Amended and Restated Non-Employee Directors Stock Option Plan. *(5) | |
10.5
|
Employment Agreement as amended February 7, 2003 between the Company and Robert J. Landis. *(7) | |
10.6
|
Employment Agreement amendment dated June 14, 2005 between the Company and Robert J. Landis. *(6) | |
10.7
|
Employment Agreement waiver dated June 14, 2005 between the Company and Robert J. Landis. *(6) | |
10.8
|
Employment Agreement as amended February 7, 2003 between the Company and Mary Jane Johnson. *(7) | |
10.9
|
Employment Agreement amendment dated June 14, 2005 between the Company and Mary Jane Johnson. *(6) | |
10.10
|
Employment Agreement waiver dated June 14, 2005 between the Company and Mary Jane Johnson.*(6) | |
10.11
|
Employment Agreement dated June 3, 2002 between the Company and Thomas C. Clay. *(10) | |
10.12
|
Comprehensive Care Corporation 2002 Incentive Plan as amended. (11) | |
10.13
|
Stock Purchase Agreement dated June 14, 2005 between the Company and Woodcliff Healthcare Investment Partners LLC. (6) | |
10.14
|
Registration Rights Agreement dated June 14, 2005 between the Company and Woodcliff Healthcare Investment Partners LLC. (6) | |
10.15
|
Marketing Agreement by and between the Company and Health Alliance Network, Inc. (15) | |
14
|
Code of Business Conduct and Ethics. (12) | |
16
|
Letter dated June 2, 2004 from Eisner LLP in concurrence with the Companys statement made concerning Eisner LLPs dismissal as the Companys principal accountant. (13) | |
21
|
List of the Companys active subsidiaries (filed herewith). | |
23.1
|
Consent of Kirkland, Russ, Murphy & Tapp P.A. (filed herewith). | |
23.2
|
Consent of Eisner LLP (filed herewith). |
42
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Number | Description and Reference | |
31.1
|
Comprehensive Care Corporation CEO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). | |
31.2
|
Comprehensive Care Corporation CFO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith). | |
32.1
|
Comprehensive Care Corporation CEO Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). | |
32.2
|
Comprehensive Care Corporation CFO Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith). |
* | Management contract or compensatory plan or arrangement with one or more directors or executive officers. | |
(1) | Filed as an exhibit to the Companys Form S-3 Registration Statement No. 2-97160. | |
(2) | Filed as an exhibit to the Companys Form 10-K for the fiscal year ended May 31, 1988. | |
(3) | Filed as an exhibit to the Companys Form 10-K for the fiscal year ended May 31, 1994. | |
(4) | Filed as an exhibit to the Companys Form 10-Q for the quarter ended February 28, 1995. | |
(5) | Filed as an exhibit to the Companys Form 8-K dated November 9, 1995. | |
(6) | Filed as an exhibit to the Companys Form 8-K dated June 14, 2005. | |
(7) | Filed as an exhibit to the Companys Form 8-K dated February 7, 2003. | |
(8) | Filed as an exhibit to the Companys Form 10-K for the Fiscal Year ended May 31, 2000. | |
(9) | Filed as an exhibit to the Companys Form 8-K dated November 25, 1998. |
|
(10) | Filed as an exhibit to the Companys Form 8-K dated June 7, 2002. | |
(11) | Filed as Appendix A to the Companys definitive proxy statement on Schedule 14A filed on January 28, 2005. | |
(12) | Filed as an exhibit to the Companys Form 10-K for the fiscal year ended May 31, 2003. | |
(13) | Filed as an exhibit to the Companys Form 8-K, dated June 4, 2004. |
|
(14) | Filed as an exhibit to Form S-8 (File No. 333-108561) filed on September 5, 2003. | |
(15) | Filed as an exhibit to the Companys Form 8-K, dated August 3, 2005. |
43
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
SIGNATURES
Pursuant to the requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934,
the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized, August 19, 2005.
COMPREHENSIVE CARE CORPORATION | ||||||
By | /s/ MARY JANE JOHNSON | |||||
Mary Jane Johnson | ||||||
President and Chief Executive Officer | ||||||
(Principal Executive Officer) | ||||||
By | /s/ ROBERT J. LANDIS | |||||
Robert J. Landis | ||||||
Chief Financial Officer and Treasurer | ||||||
(Principal Financial and Accounting Officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the Company and in the capacities and on the
dates so indicated.
Signature | Title | Date | ||
/s/ MARY JANE JOHNSON
|
President, Chief Executive Officer, and Director | August 19, 2005 | ||
/s/ ROBERT J. LANDIS
|
Chairman of the Board of Directors, Chief Financial Officer, and Treasurer (Principal Financial and Accounting Officer) | August 19, 2005 | ||
/s/ EUGENE L. FROELICH
|
Director | August 19, 2005 | ||
/s/ ROBERT PARKER
|
Director | August 19, 2005 | ||
/s/ DAVID P. SCHUSTER
|
Director | August 19, 2005 | ||
/s/ BARRY A. STEIN
|
Director | August 19, 2005 | ||
/s/ PETER JESSE WALCOTT
|
Director | August 19, 2005 |
44
Table of Contents
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Exhibit Index
Fiscal Year Ended May 31, 2005
EXHIBIT | ||||||
NUMBER | DESCRIPTION | PAGE NUMBER | ||||
21
|
List of the Companys subsidiaries | 46 | ||||
23.1
|
Consent of Kirkland, Russ, Murphy & Tapp P.A. | 47 | ||||
23.2
|
Consent of Eisner LLP | 48 | ||||
31.1
|
Comprehensive Care Corporation CEO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | 49 | ||||
31.2
|
Comprehensive Care Corporation CFO Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | 50 | ||||
32.1
|
Comprehensive Care Corporation CEO Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | 51 | ||||
32.2
|
Comprehensive Care Corporation CFO Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | 52 |
45